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Abstract  
Although the central nervous system was long perceived as the ivory tower 
without immune entities, there is growing evidence that the immune and nervous 
systems are intimated connected. These two systems have been shown to 
communicate both cellularly and molecularly under physiological and 
pathological conditions.  Despite our increasing understanding of the interplay 
between these two systems, there are still numerous open questions. In this 
thesis, I address such unanswered questions related to: the role of microglia and 
their mechanism in contributing to pathologies in Rett syndrome; the beneficial 
effects of T-cell secreted cytokines in supporting social brain function; the 
evolutionary link of the interactions between the nervous and immune systems; 
the transcription regulation of a subset of microglia population in common 
neurodegenerative diseases.   
Collectively, the current thesis is focused on the joint frontier of 
bioinformatics and experimental work in neuroimmunology. A multifaceted 
approach, that includes transcriptomics, genomics and other biomolecular 
modules, was implemented to unearth signaling pathways and mechanisms 
underlying the presenting biological phenomena. The findings of this thesis can 
be summarized as follows: 1) MeCP2 acts as a master regulator in the 
transcriptional repression of inflammatory stimuli in macrophages; 2) T-cell 
secreted IFN-γ supports social brain function through an evolutionally conserved 
interaction between the immune and nervous systems; 3) The APOE-TREM2 
  vii 
pathway regulates the microglia phenotype switch in neurodegenerative 
diseases. Provided that recent technologies allow for readily manipulating the 
immune system, the findings presented herein may create new vistas for 
therapeutic interventions in various neurological disorders. 
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CHAPTER I INTRODUCTION  
Overview of neuro-immune interactions 
The central nervous system (CNS), composed of the brain and spinal cord, was 
long considered to be an immune privileged unit that is protected by the blood-
brain-barrier and blood-cerebrospinal barrier. The interaction of the immune and 
nervous systems was often mentioned in the context of neuroinflammation, 
degeneration, injury and autoimmunity. As such, the detection of immune entities 
was often perceived as a hallmark of pathology (Villoslada et al., 2008, Shechter 
et al., 2013, Schwartz and Kipnis, 2011). 
 It has recently become clear that the immune system is also crucial for 
tissue maintenance and homeostasis (Ricklin et al., 2010). Consistent immune 
surveillance in the CNS does exist and although it is tightly regulated, it depends 
on specialized sentinels within the anatomical niches (Brynskikh et al., 2008, 
Derecki et al., 2012, Filiano et al., 2016, Kipnis, 2016, Schwartz and Kipnis, 
2011). The CNS contains a large repertoire of immune cells, including the 
parenchymal resident microglia, macrophages, dendritic cells and T cells in the 
meninges, choroid plexus and perivascular spaces (Herz et al., 2017). Together, 
these immune cells can mount robust responses to eliminate threats and 
facilitate tissue recovery when necessary. Furthermore, the immune and nervous 
systems interact intimately. Communication between the two systems is essential 
for proper brain function, and endeavors to understand this complex dialogue will 
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open new doors to treating neurological disorders through targeting the wide 
repertoire of immune cells and molecules.  
 
Microglia function under homeostasis and disease 
Microglia are the brain’s most prominent immune cells and one of the most well 
studied cells in terms of its effect on neurons (Schafer et al., 2012, Paolicelli et 
al., 2011, Zhan et al., 2014). Situated within the brain parenchyma, microglia 
serve as the tissue-resident macrophages in the CNS and participate in 
important processes in both brain development and functions. Such processes 
include constructions of neuronal circuits, monitor of synaptic function and control 
of synaptogenesis (Prinz et al., 2011, Roumier et al., 2004, Schafer et al., 2012). 
Developed from the primitive yold-sac derived macrophages, microglia colonize 
the brain during early embryonic development, and proliferate locally within the 
parenchyma without penetration from peripheral monocytes (Gomez Perdiguero 
et al., 2015, Ajami et al., 2007, Ginhoux et al., 2010).  
 Microglia play a significant role in synaptic pruning in both development 
and maintenance of homeostasis in adulthood. Synaptic pruning can be 
attributed to microglia receptors, such as CX3CR1 and CR3, or TREM2/DAP12 
recognizing ligands on the neuronal membrane (Hoshiko et al., 2012, Paolicelli et 
al., 2011, Schafer et al., 2012). During postnatal development, microglia have 
been shown to be critical in sculpting the visual circuit by pruning synapses of the 
developing lateral geniculate nucleus via CR3-mediated complement process 
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(Schafer et al., 2012). Disruption of microglia-specific CR3/C3 signaling causes 
impaired synaptic pruning and connectivity (Schafer et al., 2012). Similarly, such 
interaction between microglia-specific complement receptor and its ligands on 
developing neurons is also observed in CX3CR1-mediated synaptic pruning. 
Mice lack Cx3cr1 exhibit reduced number of microglia and decreased synapse 
pruning (Paolicelli et al., 2011). A recent study (Zhan et al., 2014) revealed the 
functional effects of microglia Cx3cr1-mediated synaptic pruning on brain 
circuitry. CX3CR1-deficient mice exhibited weaker synaptic transmission, 
decreased functional connectivity, and deficits in social behavior associated with 
autism spectrum disorder (Zhan et al., 2014).  
 To understand the roles of microglia beyond development, researchers 
have employed both genetic and pharmacological approaches to delete microglia 
from the adult brain. Parkhurst and co-workers used an Cx3cr1CreER/+::R26iDTR/+ 
genetic mouse model to specifically delete microglia upon diphtheria toxin 
administration (Parkhurst et al., 2013), while Elmore et al. followed an alternative 
approach to eliminate microglia using a colony-stimulating factor 1 receptor 
(CSF1R) antagonist (Elmore et al., 2014). However, these drastic approaches of 
eliminating microglia in short term produced mild phenotypes (Parkhurst et al., 
2013) or no behavioral effects whatsoever (Elmore et al., 2014). Interestingly, 
microglia depletion longer-term using genetic approaches resulted in synapse 
degeneration and visual deficits (Wang et al., 2016). These studies suggest that 
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microglia play a major role in normal brain physiology in both development and 
adulthood (Figure I-1).  
Microglia constantly sample their environment by their dynamic processes, 
and can be vulnerable to subtle changes/stimuli in the surrounds and become 
dysfunctional in CNS diseases. The role of microglia in CNS pathologies has 
been well-documented. For instance, obsessive-compulsive grooming in mice 
and Rett syndrome have been associated with mutations in HoxB8 (Chen et al., 
2010) and MeCP2 (Cronk et al., 2015, Derecki et al., 2012), respectively. These 
findings demonstrate that microglia dysfunction contributes significantly to 
structural and functional deficiencies of the CNS. Intriguingly, activation and 
proliferation of microglia are reported in several neurodegenerative conditions, 
including Alzheimer’s disease (AD) and Amyotrophic lateral sclerosis (ALS). 
Recent studies showed that elimination of these dysfunctional microglia is 
beneficial, and prevented synaptic degeneration (Hong and Stevens, 2016) and 
mitigated cognitive impairments independent of Aβ levels.  
In summary, numerous seminal studies have provided evidence about the 
distinct roles of microglia in synaptic pruning and sculpting brain circuitry in 
development and maintenance of homeostasis in adulthood. On the other hand, 
it has also been demonstrated that microglia become dysfunctional and have a 
delirious impact under conditions of neuronal death and aging-mediated 
inflammation (Figure I-1).  
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 In the current thesis, Chapter II describes microglia and macrophage-
intrinsic signaling pathways that are disturbed in a Rett syndrome mouse model. 
Our study provided the mechanism underlying microglia and macrophage 
phenotypes in the absence of MeCP2. Similar to Chapter II, Chapter IV 
addresses microglia phenotype switching under neurodegenerative conditions. 
 
Immune secreted molecules on behavior  
The adaptive immune system, particular through T cells, affects brain function 
under physiological conditions. Previous work demonstrated that severe 
combined immunodeficiency (SCID) mice, which lack T cells and B cells, show 
deficits in several learning and memory behavioral tasks (Derecki et al., 2010). 
Notably, learning is not affected in mice that specifically lack B cells (Radjavi et 
al., 2014), but can be rescued by reconstituting the T cells compartment 
(Brynskikh et al., 2008). These observations indicated the specific role of T cells 
on cognition. Other studies have implicated T cell influence on other brain 
functions, and lack of T cells in mice resulted in heightened susceptibility in a 
model of post-traumatic stress disorder (Cohen et al., 2006), compulsive 
grooming (Rattazzi et al., 2013) and impaired maternal behavior (Quinnies et al., 
2015).  
 A question that can be legitimately posed is how T cells affect behavior 
and brain functions under physiological conditions. Although the mechanism of 
underlying T-cell influence on normal brain function was unknown before we 
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published our study, seminal studies had provided great insights on the ability of 
meningeal T cells in affecting behavior in healthy brain. Pharmacological 
inhibition of T-cell homing (anti-VLA4 antibody) to meninges reproduced learning 
deficits as seen in SCID mice (Derecki et al., 2010). Meningeal T cells situated in 
the space between the pia, arachnoid, and dura, although proximate, they do not 
enter the brain parenchyma under homeostasis (Figure I-2) (Derecki et al., 2010, 
Filiano et al., 2016). How meningeal T cells affect brain function without entering 
the brain tissue still remains enigmatic. One plausible scenario is that T cell-
secreted soluble cytokines (such as IFN-γ, IL4, IL13, IL17, IL10 and TGF-β) can 
directly target neurons and other cells in the brain through paracrine signaling. 
Based on this, the work of this thesis attempts to address the effect of T-cell-
mediated cytokine signaling on brain behavior.  
 
A pathogen-versus-host competition  
The effect of immune cells and their secreted molecules on human’s behavior is 
well studied in the context of sickness behavior. When pathogens invade the 
body, they trigger robust immune responses, such as activation of innate immune 
cells and lymphocytes, and increased production of proinflammatory cytokines 
(Bluthe et al., 2000, Dantzer, 2009, Kelley et al., 2003). As a result, our behavior 
also changes in order to promote clearance of pathogens and increases the 
chance for host survival. Such behavior changes include: social withdrawal, 
increased sleep and decreased appetite etc. (Hart, 1988, Shakhar and Shakhar, 
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2015). This collection of behaviors is called sickness behavior and constitutes 
one of the most prominent behavioral response to an infection. Several theories 
have been proposed previously regarding the evolution of sickness behavior. A 
dominant theory in the field was proposed by Hart, who suggested that sickness 
behavior is not a maladaptive response to infection but rather an organized, 
evolved behavioral strategy to combat the infection (Hart, 1988). Recently, a 
contesting theory was proposed claiming that sickness behavior is a result of 
altruism and kin selection, and provides an evolutionary advantage to survival of 
the herd (Shakhar and Shakhar, 2015). Intriguingly, one study reported that if 
pathogen infections do not cause apparent or no symptoms of the hosts, there is 
increased social interaction mediated by the pathogen to facilitate transmission, 
as opposed to social withdrawal being a component of sickness behavior (Reiber 
et al., 2010). If pathogen-driven social aggregation cannot fully explain social 
withdrawal caused by pathogen infection, in Chapter III we propose a plausible 
theory wherein pathogen-driven prosocial and host induced sickness behavior 
are evolutionary connected and can be regarded as the result of a ‘arms-race’ 
between the host and pathogens (Filiano et al., 2017, Filiano et al., 2016, Kipnis, 
2016).  
 
Systems biology approaches  
Biology has advanced explosively since the discovery of DNA and protein in the 
early 1960s. Biologists have examined the functions and properties of each part 
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painstakingly, and thanks to that, our understanding on these individual units 
such as cell types, transcription factors and proteins has increased significantly 
(Lienert et al., 2014). However, little is known about the activities across the 
whole organism system. Understanding the output of an organism requires 
systems-level analyses as the same protein/gene may not function the same 
across all cell types and conditions, and the precise function of these individual 
units are dependent on the microenvironment of the organism such as cell types, 
spatiotemporal dynamics, and epigenetic landscape (Ideker et al., 2001). 
Advances in molecular biology, particularly in genome sequencing and high-
throughput technologies, have made it feasible to measure a good swatch of this 
complexity in a workable way, which has boosted the development of a new field 
in biology- systems biology. Systems approach to an area can be defined as a 
broad strategy to understand certain outputs as a whole (Davis et al., 2017). It 
focuses on understanding a system’s structure and dynamics, behavior and 
relationships of all the elements (Ideker et al., 2001). This powerful approach has 
resulted in the discovery of previously unknown relationships and phenomena 
and provided important insights into human diseases and mouse models of 
diseases (Davis et al., 2017, Ideker et al., 2001, Kitano, 2002). 
 
Systems approach in immunology  
The most feasible application in systems biology research is to focus on signal 
transduction cascades and molecules to provide system-level insights. One of 
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the major successes in systems immunology is to elucidate signaling pathways 
that are important in the immune system (Davis et al., 2017). This has resulted 
not only in better understanding of these signaling pathways, but also in the 
creation of efficient, reliable models to mimic and predict important aspects of 
innate immune responses (Litvak et al., 2009, Litvak et al., 2012, Ramsey et al., 
2008, Schoggins et al., 2014). This approach has become possible owing to the 
large amount of data generated per experiment and the corresponding advances 
in sequencing technology. In combination, it has greatly enhanced our 
understanding on chromatin and gene regulation, protein interactions and 
complex gene regulatory networks controlling the whole system (Lienert et al., 
2014).  
 
Tools used in systems approaches 
The generation of genomic and genomic-wide expression data comes with the 
important challenge to develop robust tools to analyze such data, and to translate 
them so that they provide an expansive view of the underlying biological 
phenomena. Initial work in this field focused on the development of techniques 
for accurate identification of differentially expressed genes using various 
statistical methods. However, the main difficulty does not lie in the identification 
of these genes, but in the interpretation of the underlying processes. Trying to 
understand individual genes from the significant list of differentially expressed 
genes is laborious and ineffective as the significant lists from different studies 
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can vary greatly. Moreover, it can be confusing when a pathway of interest 
shows moderate effect that does not appear in the top of the list  (Tian et al., 
2005). Therefore, recent efforts have focused on the development of robust tools 
and methods to analyze biological pathways rather than individual gene 
functions. 
 Two main types of approaches for analyzing biological pathways are 
discussed in the literature: 1) the over-representation approach using Gene 
Ontology (GO) and 2) the Gene Set Enrichment Analysis (GSEA).  
In the GO approach, predefined pathways representing various biological 
process, molecular function and cellular components, are used to identify 
significant pathways that are overly represented in the biological condition under 
study (Khatri and Draghici, 2005, Khatri et al., 2002). In this approach, the 
statistically significant differential expression gene list is first sorted out by one of 
the many statistical methods available. Then, the significant list, containing the 
top genes correlated to the biological condition under study, is examined against 
all GO categories in the database.  To examine the evidence of association with 
any GO category, a number of statistical models, including Fisher’s exact test 
based on the hypergeometric distribution (Cho et al., 2001) or its large-sample 
approximation X2 test, are typically implemented (Man et al., 2000). Since its 
development, this approach has found favor among biologists and has been 
widely applied for functional profiling in many microarray and genome-wide 
expression studies (Goeman et al., 2003, Ashburner et al., 2000, Oshlack et al., 
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2010). Currently, there are more than 20 existing tools (stand-alone or web-
based) for this type of analysis, most often using GO as the source of gene sets. 
Popular tools include David (Huang da et al., 2009), Gorilla (Eden et al., 2009), 
g:Profiler (Reimand et al., 2016) and BiNGO (Maere et al., 2005). Despite its 
wide application, this approach has a few major drawbacks, such as 1) the 
significant gene list may be too short to use in ontological analysis due to the 
modest biological differences and the inherent noise of genome-wide expression 
technology; 2) the gene list may be too long and the difference between the more 
significant and less significant genes is substantial. Interpretation of these cases 
can be inaccurate and ad hoc, since the order of the genes is not taken into 
consideration; 3) when independent groups study the same biological 
phenomena, the gene list from these studies may be inconsistent.  
 To address the limitations of the GO approach, an alternative and more 
robust analytical method-Gene Set Enrichment Analysis (GSEA) was developed 
(Mootha et al., 2003, Subramanian et al., 2005). This approach takes into 
consideration the pathway signature in all of the genes in an experiment and 
provides a more accurate calculation of the statistical significance by permuting 
the class labels. GSEA is the main tool used in this work for genome-wide 
expression analysis. This method is implemented to predict signaling pathways 
disturbed in the biological systems, and to integrate transcriptomes derived from 
different platforms. In combination with additional information, such as genetics 
 12 
 
and gene-regulatory networks, GSEA offers potential insights into the logic of 
dynamic neuroimmune networks at a systems level.   
 The current dissertation is focused on the joint frontier of bioinformatics 
and experimental work in the field of neuroimmunology. Transcriptomes 
downloaded from publicly available databases or generated in our research 
groups were used for pathways analysis, promoter analysis and construction of 
gene regulatory networks. The objective of this research is two-fold: 1) The 
development of a transcriptome analysis pipeline that improves our mechanistic 
understanding of the biological system of interest and the interactions of its 
biomolecular modules. 2) The use of a systems approach to study the complexity 
of biological systems by building and studying them in a context isolated from 
their high degree of natural interconnectivity. This allows for efficiently and 
inexpensively generating testable hypotheses to drive new sets of experiments. 
 
The ensuing thesis is organized as follows: 
• Chapter I discusses the emerging questions in the field of 
neuroimmunology and introduces an approach to address these 
questions. 
• Chapter II presents an RNA-seq analysis and experimental validation of 
microglia and macrophages phenotypes disturbed in a Rett syndrome 
mouse model, MeCP2-null mice. A previous study had demonstrated that 
brain resident microglia contribute to pathologies in the MeCP2-null mice. 
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However, the mechanism of how microglia become dysfunctional and 
contribute to Rett phenotypes is unknown. To define the functional role of 
MeCP2 in microglia and macrophages (which were also found to be 
reduced in numbers in certain tissues), we performed global gene-
expression profiling and pathway analysis. We show that macrophages 
responses to three stimuli are all intrinsically impaired in the absence of 
MeCP2, suggesting MeCP2 as a master regulator in gene expression in 
macrophages.   
• In Chapter III, the communication of T cell-secreted cytokines and brain-
circuit mediated behaviors is explored. Despite being ‘immune-privileged’, 
the CNS uses the assistance of the immune system both under 
homeostasis and in diseased conditions (Filiano et al., 2017). T cell and its 
secreted cytokines have been previously reported to play a critical role in 
spatial learning (Derecki et al., 2010). Lack of T cells are linked with other 
behavioral deficits. To uncover the role of T-cell and its secreted cytokines 
in regulating various brain functions and behaviors, we performed meta- 
analysis of transcriptomes downloaded from a public database. We 
discovered an unexpected novel connection between T-cells mediated 
IFN-γ responses and brain transcriptomes exposed to social environment 
enrichment. Following experiments done at our collaborator’s lab using 
genetic mouse models and behavioral assays, we validated this prediction 
and identified the mechanism underlying such a connection. we further 
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provided evidence that the novel role of IFN-γ in supporting social 
behavior is also conserved in rat, zebrafish and flies. These findings allow 
us to propose a plausible hypothesis regarding the evolution of sickness 
behavior.  
• Chapter IV focuses on microglia phenotype switching in 
neurodegenerative diseases, a hotly debated field. Modern RNA-seq 
analysis shows that microglia transcriptome exhibits an unique 
transcriptional signature under homeostasis, and this homeostatic 
microglia is tightly controlled by the TGFβ pathway (Butovsky et al. 2013; 
Gautier et al. 2012; Hickman et al. 2013). However, microglia become 
dysfunctional and lose their homeostatic signature in CNS diseases. To 
study microglia phenotype switches in pathological conditions, we 
performed meta-analysis of microglia transcriptome under various 
conditions that were deposited in the public database. We were able to 
identify a unique microglia subset, dubbed MGnD, that are shared among 
several neurodegenerative diseases conditions. Pathway analysis 
revealed the signaling pathways regulating MGnD signature. In 
combination with promoter analysis and transcriptional factor binding site 
cluster analysis, we constructed the gene regulatory network orchestrating 
the microglia phenotype switch in neurodegenerative conditions.  
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• Chapter V describes in detail the novel approach of GSEA-driven meta-
analysis method that I developed and applied in the work of Chapters II, 
III, IV.  
• Chapter VI provides a brief summary of the conclusions and main 
contributions of the present dissertation and proposes potential vistas of 
future research.  
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Figure adopted from (Herz et al., 2017). 
Figure I-1 CNS modulating roles of microglia. 
Microglia not only contribute to neuronal health but also participate in neuronal dysfunction and 
morphologic abnormalities. Left: the neuro-supportive role of microglia is regulated by the 
secretion of trophic factors, such as BDNF and the participation of pruning as part of the normal 
developmental program. The phagocytic activity is important for the cleanup of senescent cells 
and debris and slowing the toxic effect of amyloid-β. Right: In the absence of vital microglia, the 
CNS loses a necessary facilitator of neuronal synaptic function. Interactions with neurons 
promote plasticity, but aberrant activity can enable intense inflammatory reactions that lead to 
CNS pathology. Phagocytic pursuit declines with age and can promote the progression of 
pathology and give rise to cognitive regression.   
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Figure adopted from (Filiano et al., 2017). 
 
Figure I-2 Immune cells reside in meningeal spaces.  
A schematic representation of the three membranes that comprise the meninges: the dura, 
arachnoid and pia. A full complement of immune cells has been observed in the dura and 
subarachnoid layers of the meninges and in the cerebrospinal fluid (CSF). DC, dendritic cell. 
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CHAPTER II METHYL-CPG BINDING PROTEIN 2 REGULATE 
MICROGLIA AND MACROPHAGE GENE EXPRESSION IN 
RESPONSE TO INFLAMMATORY STIMULI 
 
 
The work presented in this chapter has been published as:  
 
 
James C. Cronk, Noel C. Derecki, Emily Ji, Yang Xu, Aaron Lampano, Igor 
Smirnov, Wendy Baker, Geoffrey T. Norris, Ioanna Martin, Nathan Coddington, 
Yochai Wolf, Stephan Turner, Alan Aderem, Alexander L. Klibanov, Tajie H. 
Harris, Steffen Jung, Vladimir Litvak, and Jonathan Kipnis (2015). Methyl-CpG 
binding protein 2 regulates microglia and macrophage gene expression in 
response to inflammatory stimuli. Immunity 42, 679-91. 
 
My contribution to this work include RNA-seq analysis, functional pathways 
analysis and experimental validations for the predicted pathways. 
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Chapter II Methyl-CpG binding protein 2 regulate microglia and 
macrophage gene expression in response to inflammatory stimuli 
Summary 
Mutations in MECP2, encoding the epigenetic regulator methyl-CpG-binding 
protein 2, are the predominant cause of Rett syndrome, a disease characterized 
by both neurological symptoms and systemic abnormalities. Microglia 
dysfunction is thought to be contributing to the disease pathogenesis, and here 
we found microglia become activated and subsequently lost with disease 
progression in Mecp2-null mice. Mecp2 was found to be expressed in peripheral 
macrophage and monocyte populations, several of which also became depleted 
in Mecp2-null mice. RNA-seq revealed increased expression of glucocorticoid- 
and hypoxia-induced transcripts in Mecp2-deficient microglia and peritoneal 
macrophages. Furthermore, Mecp2 was found to regulate inflammatory gene 
transcription in response to TNF stimulation. Postnatal re-expression of Mecp2 
using Cx3cr1creER increased the lifespan of the otherwise Mecp2-null mice. These 
data suggest that Mecp2 regulates microglia and macrophage responsiveness to 
environmental stimuli to promote homeostasis. Dysfunction of tissue-resident 
macrophage might contribute to the systemic pathologies observed in Rett 
syndrome. 
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Introduction 
Rett syndrome, caused primarily by mutations in methyl-CpG binding protein 2 
(MeCP2) (Amir et al., 1999), features prominent neurologic sequelae (Chahrour 
and Zoghbi, 2007); accordingly, efforts to understand the function of MeCP2 
have been focused largely on its role in neurons (Chahrour and Zoghbi, 2007). 
Recent reports have found expression and roles for Mecp2 in astrocytes (Ballas 
et al., 2009, Lioy et al., 2011, Yasui et al., 2013), oligodendrocytes (Nguyen et 
al., 2013), and microglia (Derecki et al., 2012, Maezawa and Jin, 2010). In 
addition, Mecp2 is expressed in many tissues (Shahbazian et al., 2002). Thus, 
mutations in MeCP2 likely affect multiple organ systems and cell types, which is 
indeed reflected in the complexity of symptoms associated with Rett syndrome 
(Chahrour and Zoghbi, 2007, Dunn and MacLeod, 2001). While neurological 
symptoms are prominent, most girls with Rett syndrome also suffer from somatic 
impairments, including stunted growth, osteopenia, scoliosis, and digestive 
difficulties (Chahrour and Zoghbi, 2007, Dunn and MacLeod, 2001). 
Many tissue-resident macrophages, including microglia, originate during 
embryonic hematopoiesis, beginning in the yolk sac and moving to the fetal liver. 
These precursor cells disseminate throughout tissues during embryogenesis, 
engraft within nearly every organ system, and form self-renewing 
populations(Ginhoux et al., 2010, Kierdorf et al., 2013, Schulz et al., 2012, Yona 
et al., 2013)). Other populations of tissue-resident macrophages, such as 
intestinal lamina propria intestinal macrophages, are constantly replenished by 
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circulating monocytes (Bain et al., 2013, Varol et al., 2009). The functional roles 
of tissue-resident macrophages vary greatly and are dependent upon location 
and context (Davies et al., 2013). However, all tissue-resident macrophages 
appear to be unified by their role as provisioners of homeostatic maintenance 
(Davies et al., 2013). Further, monocyte-derived inflammatory non-resident 
macrophages are critical for effective response to infection and injury. In this 
context, these cells rely on a carefully balanced network of skewing paradigms, 
which direct macrophage function including the initiation and resolution of 
inflammation, clearance of debris and pathogens, and assistance in the healing 
process (Sica and Mantovani, 2012). Notably, mice lacking macrophage colony 
stimulating factor 1 receptor (CSF-1R) are deficient in all macrophages and are 
characterized by multiple organ failures and shortened lifespan (Dai et al., 2002), 
emphasizing the critical importance of macrophages in support of bodily tissues. 
Our previous work demonstrated that engraftment of wild-type monocytes 
into the brains of Mecp2-null mice (through bone marrow transplantation) 
extends lifespan by several months and improves neurologic and behavioral 
outcomes (Derecki et al., 2012). In addition, phagocytosis of apoptotic cells in 
vitro is impaired in Mecp2-null microglia. Although brain engraftment by 
monocytes with bone-marrow transplant is crucial for significant lifespan 
extension in Mecp2-null mice (Derecki et al., 2012), we did not explore the 
possibility that Mecp2 might be important for the normal function of other 
mononuclear phagocytes. 
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Here we demonstrated that numerous populations of macrophages and 
monocytes expressed Mecp2, and that Mecp2- null mice become deficient in 
several macrophage populations, including microglia. We next showed that 
postnatal re-expression of Mecp2 under a Cx3cr1-inducible promoter resulted in 
a lifespan increase in otherwise Mecp2-null mice. In order to elucidate 
mechanisms behind the macrophage defects in the context of Mecp2-deficiency, 
we demonstrated by RNA-Seq that acutely isolated Mecp2-null microglia and 
peritoneal macrophages displayed changes in specific signaling pathways, 
suggesting that Mecp2 is an important regulator of microglia and macrophage 
gene expression. Further in vivo and in vitro validation studies confirmed that 
Mecp2 is important for proper transcriptional regulation of multiple gene-
expression programs in macrophages. Overall, these results demonstrated that 
Mecp2 is an important epigenetic regulator of macrophage response to stimuli 
and stressors. 
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Methods 
Animals 
Male and female C57Bl/6J, B6.129P2(C)-Mecp2tm1.1Bird/J, B6.129P2-
Mecp2tm2Bird/J, and B6.129P-Cx3cr1tm1Litt/J mice were purchased from Jackson 
Laboratories and/or bred in house using stock obtained from Jackson 
Laboratories. Cx3cr1creER mice were kindly provided by S. Jung (Weizmann 
Institute of Science) and were maintained in our laboratory on C57Bl/6J 
background. All animals were housed in temperature and humidity controlled 
rooms, and maintained on a 12 hr/12 hr light/dark cycle (lights on at 7:00). All 
strains were kept in identical housing conditions. Mice were scored for pathology 
based on a 3-point scale across four categories: hind-limb-clasping, tremors, 
gait, and general appearance. For each category, 3 = wild-type, 2 = mid-
phenotypic, and 1 = late-phenotypic. Mice that scored in-between 3 and 2 were 
considered early/pre-phenotypic. Approximate ages for prephenotypic mice were 
4–5 weeks, and for late-phenotypic 8–12 weeks; however, all experiments were 
performed and labeled based on actual phenotype of the mice. All procedures 
complied with regulations of the Institutional Animal Care and Use Committee at 
The University of Virginia. 
Tamoxifen treatment 
Tamoxifen (Sigma T5648) was solubilized in corn oil (Sigma) at 10 mg/ml. Mice 
were injected three times, subcutaneously, between the shoulder blades, at 48 hr 
intervals at a dose of 100 mg/kg. For tamoxifen feeding, mice were placed on 
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tamoxifen diet TD.130856 (Harlan Laboratories) for up to 3 months before 
analysis, while controls were left on normal mouse chow (Harlan Laboratories). 
RNA-Seq analysis 
Total RNA was extracted using the RNeasy mini kit (QIAGEN). RNA-seq was 
performed by Hudson Alpha Genomic Services Laboratory. Statistical analysis 
and data post-processing were performed with in-house developed functions 
using Matlab (Litvak et al. 2009; Litvak et al. 2012). For transcriptome analysis of 
wild-type and Mecp2-null microglia and peritoneal macrophages, genes were 
selected for inclusion on the basis of filtering for minimum log2 expression 
intensity (>4). 
Gene set enrichment analysis 
Gene set enrichment analysis (GSEA) is an analytical tool for relating 
differentially regulated genes to transcriptional signatures and molecular 
pathways associated with known biological functions (Subramanian et al., 2005). 
The statistical significance of the enrichment of known transcriptional signatures 
in a ranked list of genes was determined as described (Subramanian et al., 
2005). To assess the phenotypic association with Mecp2 deficiency, we used the 
list of genes that was ranked according to differential gene expression in Mecp2-
null and wild-type microglia. We used 4,722 gene sets from the Molecular 
Signature Database C2 version 4.0 and 32 custom gene sets including hypoxia 
and glucocorticoid-stimulated gene sets. 
Quantitative chromatin immunoprecipitation analysis 
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For ChIP analysis, formalin-fixed cells were sonicated and processed for 
immunoprecipitation essentially as described (Ning et al., 2011). In brief, 1.5 x107 
BMMs were cross-linked for 10 min in 1% paraformaldehyde, washed, and lysed. 
Chromatin was sheared by sonication (5 cycles x 60 sec each cycle at 30% 
maximum potency) to fragments of approximately 150 bp. For Mecp2 ChIP, the 
sheared chromatin was incubated with anti-Mecp2 antibodies (ABE171) 
(Millipore), and then immunoprecipitated using anti-rabbit immunoglobulin G 
(IgG) Dynabeads (Invitrogen) pre-conjugated with anti-Chicken IgY antibodies 
(ab6877) (Abcam), washed, and eluted. For acH4 ChIP, the sheared chromatin 
was incubated with anti-rabbit IgG Dynabeads (Invitrogen) pre-conjugated with 
antibodies acH4 (06-598) (Upstate) or Isotype control IgG1 (BD Pharmigen), 
washed, and eluted. Eluted chromatin was reverse-cross-linked, and DNA was 
purified using phenol/chloroform/isoamyl extraction. 
For quantitative ChIP, immunoprecipitated DNA samples were amplified 
with Fkbp5-promoter-specific primers (Forward: TGCACTGCCTATGCAAATGA 
and Reverse: AGCTTCCTCCATCCCTCTT) using TaqMan quantitative PCR 
analysis. PCR samples from IgY-ChIPs served as a negative control. 
Accession numbers 
The Gene Expression Omnibus (GEO) accession number for the RNA-seq data 
reported in this paper is GSE66211, and the Gene Expression Omnibus (GEO) 
accession number for the ChIP-seq data reported in this paper is GSE66501. 
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Results 
Microglia become activated and subsequently depleted with disease 
progression in Mecp2-Null mice 
Previous data (Derecki et al. 2012) showing a role for microglia in disease 
pathogenesis of Mecp2-deficient mice led us to study in greater detail the role of 
Mecp2 in microglia and developmentally related peripheral tissue-resident 
macrophages. Wild-type microglia were found to express Mecp2, as examined 
by intracellular flow cytometric labeling (Figure II-1A) or by in situ 
immunofluorescence (Figure II-1B). This is in line with previously reported results 
(Maezawa and Jin, 2010). We next investigated how loss of Mecp2 affects 
microglia in vivo. Using a thinned-skull technique, we performed intravital two-
photon imaging on pre- and late-phenotypic Mecp2-null and wild-type mice. We 
observed that pre-phenotypic Mecp2- null microglia had significantly smaller 
somas (similar to Mecp2-null neurons and astrocytes), whereas late-phenotypic. 
Mecp2-null microglia soma were larger in size as compared to wild-type (Figure 
II-1C and 1D), suggestive of microglia activation(Maezawa and Jin, 2010). In 
addition, in situ Sholl analysis demonstrated that while pre-phenotypic Mecp2-
null microglia were not different from wild-type, microglia from late-phenotypic 
mice displayed significantly reduced process complexity in three examined brain 
areas (hippocampus, neocortex, and cerebellum; Figure II-1E). Together, the 
findings of increased soma size and decreased process complexity suggested 
that Mecp2-null microglia became activated with disease progression. Indeed, 
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qRT-PCR of acutely isolated Mecp2-null microglia from pre- and late-phenotypic 
mice showed increased Tnf mRNA encoding the pro-inflammatory cytokine tumor 
necrosis factor (TNF) (Figure II-1F) while Tgfb1 transcription, required for 
microglia maintenance (Butovsky et al., 2014), was decreased in late-phenotypic 
microglia (Figure II-1G).  
We next examined Mecp2-null microglia by flow cytometry, which revealed 
a progressive loss of microglia in Mecp2-null mice from pre- to late-phenotypic 
stage (Figure II-1H and 1I). Loss of microglia was found throughout the brain 
Figure II-1J). The loss was also observed in brains of late-phenotypic Mecp2-null 
mice by immunohistochemistry. Further, immunohistochemical staining for Iba1, 
a microglial marker, and for cleaved caspase 3 (CC3), a marker of apoptotic 
cells, revealed sporadic CC3+ microglia in late-phenotypic Mecp2-null brains. In 
sum, these data suggest that in the context of Mecp2-deficiency, microglia 
become activated and are lost with disease progression. 
 
Meningeal macrophages are lost with disease progression in Mecp2-Null 
mice 
When analyzing microglia by intravital two-photon microscopy, we also observed 
significant morphologic disruption of Cx3cr1GFP/+ meningeal macrophages in vivo 
in late-phenotypic Mecp2-null mice suggestive of reactive phenotype (Figure 
II-2A). To assess meningeal macrophages in further detail, we performed 
immuno- fluorescent labeling of meninges from pre-, mid-, and late-phenotypic 
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Mecp2-null mice using antibodies against CD163 and F4/80. A progressive loss 
of macrophages at the late-phenotypic state was evident in Mecp2-null mice 
(Figure II-2B and 2C). Perivascular macrophages in the meninges are 
F4/80+CD163+, whereas a separate meningeal macrophage population is 
F4/80+CD163– (Davies et al., 2013). When we analyzed these populations 
separately, we found that perivascular macrophages (F4/80+CD163+) were 
progressively lost in Mecp2- null mice (Figure II-2D), whereas non-perivascular 
meningeal macrophages (F4/80+ CD163–) were not significantly depleted (Figure 
II-2E). 
 
Peripheral monocytes and macrophages express Mecp2, and some are lost 
in Mecp2-Null mice 
Given the phenotype of meningeal macrophages and microglia, we decided to 
expand our analysis to additional populations of peripheral macrophages. Many 
tissue-resident macrophages, including microglia, originate from similar 
progenitor pools during embryogenesis (Ginhoux et al., 2010, Hoshiko et al., 
2012, Kierdorf et al., 2013, Schulz et al., 2012, Yona et al., 2013), and might 
therefore share pathologies in the context of Mecp2-deficiency. We found that all 
tested tissue-resident macrophages expressed Mecp2 (Figure II-3A and 3B). In 
addition, Ly6clo monocytes, which represent a longer-lived resident population in 
the blood (Yona et al., 2013) also expressed Mecp2 (Figure II-3B). In contrast, 
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Ly6chiCCR2+ monocytes and neutrophils expressed low or undetectable amounts 
of Mecp2 (Figure II-3C). 
As expected, based on the microglia and meningeal macrophage results 
described above, we found reductions of other peripheral macrophage 
populations in Mecp2-null mice. Unlike microglia, CD64+F4/80+CD11b+ 
macrophages from the small intestine were reduced in both pre- and late-
phenotypic Mecp2-null mice (Figure II-3D and 3E). Circulating Ly6clo monocytes 
were also reduced in number in both pre- and late-phenotypic Mecp2-null mice 
(Figure II-3F and 3G). 
Because both CD64+ F4/80+ CD11b+ intestinal macrophages and Ly6clo 
monocytes share their derivation from Ly6chi monocytes (Bain et al., 2013, Varol 
et al., 2009, Yona et al., 2013), it is possible that the reductions seen in these 
populations even in pre-phenotypic Mecp2-null mice might reflect their common 
origin. To this end, we tested whether Ly6chi monocytes from bone marrow were 
impaired in their ability to differentiate and/or proliferate as macrophages in 
response to MCSF in vitro. We found that Mecp2-null Ly6chi monocytes 
differentiated into macrophages with similar kinetics to wild-type and produced 
similar numbers of macrophages per monocyte, making it an unlikely possibility 
that Mecp2 is directly necessary for Ly6chi monocyte differentiation or 
macrophage proliferation in the absence of other factors. 
Although Mecp2 did not affect differentiation or proliferation in vitro, we 
hypothesized that Mecp2 might play a role in monocyte/macrophage responses 
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within the context of the full disease caused by whole-animal Mecp2-deficiency. 
To test this possibility, we depleted monocytes and macrophages using 
intravenous (i.v.) clodronate liposomes in wild-type and Mecp2- null littermates 
(mid-phenotypic, 6 weeks to allow for immune system maturation but prior to the 
peak of disease) and measured the repopulation of resident monocytes. DiI 
liposomes were injected i.v. 2 days after clodronate liposome injection, similar to 
published protocols (Sunderkotter et al., 2004). Ly6chi monocytes released from 
the bone marrow become DiI labeled and can be tracked in their differentiation to 
Ly6clo monocytes. On day 5 post-clodronate injection (day 3 post DiI), wild-type 
and Mecp2-null mice had, as expected, begun to reconstitute their circulating 
monocyte populations, with a non-significant trend toward fewer total (Figures 
II.3H and 3I). However, when total monocytes were examined, Mecp2-null mice 
had significantly fewer resident Ly6clo monocytes as compared to wild-type 
(Figure II-3J). In addition, when only DiI+ monocytes were examined 
(representing only the circulating monocytes present on day 2 post-clodronate 
injection), DiI+ monocytes in wild-type mice had almost completely differentiated 
into Ly6clo resident monocytes, whereas Mecp2-null mice displayed a deficit in 
Ly6clo monocyte differentiation (Figure II-3K). The fact that some populations 
were deficient in the pre-phenotypic state (resident monocytes and intestinal 
macrophages), but others were lost progressively (microglia and meningeal 
perivascular macrophages) led us to hypothesize that Mecp2 is likely playing a 
complex role in macrophage biology which is not limited to macrophage survival 
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and/ or death. Of note, we did not observe any difference in F4/80+CD163– 
meningeal macrophages (Figure II-2E) or splenic red pulp macrophages (data 
not shown), which also express Mecp2 (Figure II-3A and 3B), further suggesting 
that the role of Mecp2 in macrophages is complex or upstream of cell loss and/or 
death, because not all macrophage populations were equally affected by Mecp2-
deficiency. In addition, our data regarding microglia suggested inflammatory 
activation (Figure II-1−1G), implicating Mecp2-deficiency in processes beyond 
simple loss of microglia/macrophages. Overall, the data suggested a complex 
role for Mecp2 in macrophages, consistent with its previously described role in 
other cell types as an epigenetic regulator, affecting a multitude of genes (Guy et 
al., 2011). 
 
Postnatal expression of Mecp2 via Cx3cr1creER in the otherwise Mecp2-
Deficient mice increases lifespan  
Previously we showed that transplantation of Mecp2-null mice with wild-type 
bone marrow increases lifespan, and that engraftment of microglia-like cells into 
the brain is important for this effect (Derecki et al., 2012). More recently, 
Cx3cr1creER mice have become available (Goldmann et al., 2013, Yona et al., 
2013), and microglia are among a subset of macrophages with high expression 
of CX3CR1 during adulthood (Jung et al., 2000). Thus, the Cx3cr1creER mouse 
can be used to efficiently target microglia, in addition to other CX3CR1-
expressing monocytes and macrophages. Therefore, we crossed Cx3cr1creER 
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mice with Mecp2Lox-stop mice and their offspring (Cx3cr1creER/+ Mecp2Lox-stop/y) 
were treated with tamoxifen (~9 weeks of age), when symptoms just started to 
appear. In line with our previous finding with bone-marrow transplantation 
(Derecki et al., 2012), the lifespan of tamoxifen-treated Cx3cr1creER/+ Mecp2Lox-
stop/y mice was significantly extended (Figure II-4A) and weight loss was reversed 
as compared to oil-treated controls (Figure II-4B), supporting the importance of 
microglia and macrophages in the arrest of pathology. In order to test for 
specificity of Mecp2 expression after tamoxifen treatment, we placed 
Cx3cr1creER/+ Mecp2Lox-stop/y mice on a tamoxifen diet for 3 months to maximize 
expression in any cells that would have the potential to recombine. As expected, 
we found no significant expression of Mecp2 in T or B cells, and partial re-
expression in monocytes (Figure II-4C), as previously reported (Yona et al., 
2013). In the spleen, we found a small percentage of Mecp2-expressing red pulp 
macrophages (~20%) (Figure II-4D), consistent with the fact that red pulp 
macrophages do not express high amounts of CX3CR1. However, CD64+F4/80+ 
intestinal macrophages and microglia, in which CX3CR1 is highly expressed, had 
nearly 100% Mecp2 recombination (Figure II-4E and 4F). Non-microglia cells in 
the CNS displayed no Mecp2 recombination (Figure II-4G). Together, these 
results support that Mecp2-deficiency in microglia/macrophages contributes to 
pathology and that restoring Mecp2-mediated regulation of transcriptional 
responses has the potential to mediate benefits in the context of whole-body 
Mecp2-deficiency. 
 33 
 
 
Mecp2 regulates glucocorticoid and hypoxia responses in microglia and 
peritoneal macrophages 
In order to define the functional role of Mecp2 in macrophages, we examined the 
global gene-expression profile in microglia and peritoneal macrophages derived 
from Mecp2-null mice. We detected increased expression of glucocorticoid-
induced transcriptional signature genes in Mecp2-null cells when compared to 
their wild-type counterparts, suggesting that Mecp2 functions as a repressor of 
this pathway (Figure II-5A-5D). Among the dysregulated genes in Mecp2-null 
microglia and peritoneal macrophages, Fkbp5, a canonical glucocorticoid target 
gene, was strongly upregulated (Figure II-5A and 5C). A number of studies have 
demonstrated that Mecp2 directly represses the Fkbp5 gene (Nuber et al., 2005, 
Urdinguio et al., 2008). Using chromatin immunoprecipitation (ChIP) analysis, we 
demonstrated Mecp2 binding to the Fkbp5 gene promoter in bone marrow-
derived macrophages (BMDM) (Figure II-5E). Furthermore, Mecp2 deletion 
resulted in increased amounts of histone H4 acetylation at cis-regulatory regions 
of Fkbp5 gene under basal conditions (Figure II-5F). These results suggest that 
Mecp2 restrains Fkbp5 gene expression through epigenetic mechanisms. ChIP 
analysis demonstrated the binding of nuclear receptor co-repressor 2 (Ncor2) 
and histone deacetylase 3 (Hdac3) to the promoter region at the Fkbp5 gene. 
These results are consistent with the well-established role of Mecp2 in the 
recruitment of the Ncor2 and Hdac3 complex to target genes (Ebert et al., 2013, 
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Lyst et al., 2013). We next examined the Fkbp5 gene-expression pro- file in 
dexamethasone-treated wild-type and Mecp2-null macrophages. Our results 
revealed that Mecp2 controls the sensitivity of the Fkbp5 gene to glucocorticoid 
stimulation. Mecp2 deletion resulted in the upregulation of Fkbp5 gene 
expression under dexamethasone stimulation at a low dose normally incapable 
of triggering Fkbp5 gene expression (Figure II-5G). 
 We noticed that the glucocorticoid-induced gene set contains a number of 
hypoxia-inducible genes. Furthermore, our gene set enrichment analysis 
demonstrated significantly increased expression of a subset of hypoxia-inducible 
genes in Mecp2-null microglia (Figure II-5H and 5I). To validate the cell intrinsic 
role for Mecp2 in the negative regulation of these hypoxia-inducible genes, we 
cultured BMDM under either normoxia or hypoxia conditions (1% O2) and 
examined their mRNA using quantitative PCR analysis. We validated increased 
expression of three canonical hypoxia-inducible genes, Hif3a, Ddit4, and Cyr61 
in Mecp2-null macrophages cultured under hypoxia conditions when compared to 
their wild-type counterparts (Figure II-5J), confirming a role for Mecp2 in 
regulation of at least a subset of hypoxia-induced gene transcripts. 
 
Mecp2 restrains inflammatory responses in macrophages 
Our RNA-seq analysis revealed increased expression of Tnf induced 
transcriptional signature genes in Mecp2-null microglia cells when compared to 
their wild-type counterparts. These results indicate that Mecp2-deficiency leads 
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to dysregulation of inflammatory responses in microglia and macrophages. To 
validate this finding, we examined the role of Mecp2 in the regulation of TNF-
induced inflammatory responses in macrophages. We observed increased 
expression of Il6, Tnf, Cxcl2, Cxcl3, and Csf3 genes in TNF-stimulated Mecp2-
null BMDM when compared to wild-type counterparts (Figure II-6A). In order to 
corroborate these findings in vivo, we examined the inflammatory response of 
resident peritoneal macrophages. Mice were injected intraperitoneally with TNF, 
allowed to respond for 6 hr, and then peritoneal cells were collected by lavage. 
Cells from peritoneal lavage were positively selected for F4/80+ macrophages via 
AutoMACS. Peritoneal macrophages from Mecp2- null mice injected with TNF 
displayed an altered transcriptional response as compared to wild-type (Figure 
II-6B), including both over- and under-expression of multiple TNF response 
genes. No differences in baseline expression were evident in peritoneal 
macrophages from mice after saline treatment. Targets observed in vitro with 
TNF stimulated BMDMs were also overexpressed in peritoneal macrophages 
stimulated with TNF in vivo, suggesting that Mecp2 has consistent transcriptional 
roles across macrophage populations (Figure II-6A and 6B). Csf3, the gene 
encoding granulocyte-colony stimulating factor (GCSF), was overexpressed in 
TNF-stimulated Mecp2-null macrophages both in vitro and in vivo (Figure II-6A 
and 6B). Late-phenotypic Mecp2-null mice without any manipulation also 
displayed increased GCSF protein in serum (Figure II-6C). Because a well-
established effect of GCSF is to stimulate neutrophil production (Bendall and 
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Bradstock, 2014), we examined neutrophil numbers in Mecp2-null mice. Indeed, 
we found that Mecp2-null mice develop severe neutrophilia. In addition, GCSF is 
known to drive the egress of hematopoietic stem cells (HSC) from the bone 
marrow (Bendall and Bradstock, 2014) and as expected, late-phenotypic Mecp2-
null mice also became progressively deficient in bone marrow HSC with disease 
progression. In order to test whether or not neutrophilia and HSC loss play a role 
in the disease, we treated Mecp2-null mice with a neutralizing anti-GCSF 
antibody beginning at age 6-7 weeks (a mid-phenotypic time-point). Flow 
cytometric analysis revealed rescue of neutrophilia (Figure II-6D) and prevention 
of HSC loss. The treatment also moderately increased the lifespan of Mecp2-null 
mice (Figure II-6E). Together, these findings implicate Mecp2 in control of the 
macrophage inflammatory response, which might have downstream implications 
for complex disease processes in the context of Mecp2-deficiency. 
 37 
 
 
 
 
Figure II-1 Microglia become activated and subsequently depleted with disease progression 
in Mecp2-null mice.  
(A) Flow cytometry demonstrating Mecp2 expression in microglia from whole brain. (B) 
Cryosections from Cx3cr1GFP/+ wild type mice demonstrating Mecp2 expression in microglia 
(scale bar, 20 µm). Images were cropped from larger images to allow for better visualization of 
Mecp2 localization within microglia. (C) Representative stills from 2-photon live-imaging of late-
phenotypic Cx3cr1GFP/+ wild type and Cx3cr1GFP/+ Mecp2-null microglia. (D) Quantitative 
assessment of microglial soma size measured by two-photon intravital microscopy in pre- and 
late-phenotypic Cx3cr1GFP/+ wild type and Cx3cr1GFP/+ Mecp2-null mice (*, p < 0.05; **, p < 
0.01; two-way ANOVA with Bonferroni post-test; n = 3 mice per group. Error bars represent 
SEM). (E) Sholl profiles for pre- and late-phenotypic wild type and Mecp2-null microglia in 
hippocampus and neocortex showing intersections; (***, p<0.001; **, p<0.01; *, p<0.05; two-
way ANOVA with Bonferroni post-test, n = 3 mice per group with 3 separate areas from slices 
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from identical brain structures analyzed per each genotype. Data are presented as mean ±SEM). 
(F,G) qRT-PCR of Tnf (F) and Tgfb1 (G) from pre- and late-phenotypic Mecp2-null mice and 
their age-matched wild type controls (*, p < 0.05; **, p < 0.01; two-way ANOVA with 
Bonferroni post-test, n = 3 mice for all groups except late-phenotypic wild type for which n = 5. 
Data are presented as mean ± SEM). (H) Flow cytometric analysis demonstrating the percentage 
of microglia in whole brain preparations in Mecp2-null mice with increasing disease severity. 
Numbers show the percentage of Hoechst+ (nucleated) singlet CNS cells that are 
CD45loCD11b+ microglia. (I) Quantification of microglia in pre- and late- phenotypic Mecp2-null 
mice as compared to age-matched wild type controls. Cells were gated on Hoechst+ (nucleated 
cells), Singlets, Size, and CD45lo/neg to exclude peripheral immune cells. (Two-way ANOVA with 
Bonferroni post-test; pre-phenotypic, not significant. Late-phenotypic; *, p<0.05. Pre-phenotypic 
vs. late-phenotypic Mecp2-null; *, p < 0.05. Overall main effect wild type vs. Mecp2-null; **, p 
< 0.01. n = 7 pairs of wild type and Mecp2-null mice pooled from 3 independent experiments for 
pre-phenotypic groups and n = 6 pairs of wild type and Mecp2-null mice pooled from 4 
independent experiments for late-phenotypic groups. Error bars represent SEM). (J) Brain region-
specific microglia percentages as measured by flow cytometry in late-phenotypic Mecp2-null 
mice and age-matched wild type controls (*, p < 0.05; **, p < 0.01; ***, p < 0.001; two-way 
ANOVA; n = 6 mice per group. Error bars represent SEM). 
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Figure II-2 Meningeal macrophages are lost with disease progression in Mecp2-null mice.  
(A) Representative stills from intravital two-photon microscopy of phenotypic Mecp2-null 
meningeal macrophages demonstrating abnormal/activated morphology. (B) Representative 
images of wild type, mid and late-phenotypic Mecp2-null meningeal macrophages. Upper panels, 
scale bar = 200µm. Lower panels, scale bar = 100µm. (C) Quantification of total meningeal 
macrophages in late-phenotypic Mecp2-null mice as compared to wild type, pre- and mid-
phenotypic Mecp2-null (One-way ANOVA with Bonferroni post-test; **, p < 0.01. Error bars 
represent SEM). (D) Quantification of F4/80+CD163+ perivascular meningeal macrophages in 
late-phenotypic Mecp2-null mice as compared to wild type, pre and mid-phenotypic Mecp2-null 
(One-way ANOVA with Bonferroni post-test; *, p < 0.01; **, p < 0.01. Error bars represent 
SEM). (E) Quantification of F4/80+CD163−non-perivascular meningeal macrophages in Mecp2-
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null mice as compared to wild type (One-way ANOVA with Bonferroni post-test. Error bars 
represent SEM). 
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Figure II-3 Peripheral monocytes and macrophages express Mecp2, and some are lost in 
Mecp2-null mice.  
(A) Example gating strategy for Mecp2 expression; shown are red pulp macrophages from spleen. 
(B) Mecp2 expression in macrophage and monocyte populations as measured by intracellular 
flow cytometric staining in wild type and Mecp2-null mice. Gating: Bone marrow (BM)-resident 
macrophages- size, CD45+, Singlets, Ly6c−, F4/80+, CD11blo, CD3− , SSClo; Splenic red pulp 
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macrophages- CD45+, Singlets, F4/80+, B220−, Size, SSClo, Ly6g−, Ly6c; Peritoneal resident 
macrophages- Size, Singlets, CD45+, CD11b+, F480hi; Intestinal macrophages- Singlets, viability, 
CD45+, CD11b+, CD64+; Splenic Ly6clo monocytes, CD45+, Singlets, CD115+, SSClo Ly6clo. (C) 
Flow cytometric Mecp2 staining in inflammatory monocytes (Ly6chiCCR2+) and neutrophils 
(Ly6ghiCD11b+). Gating: Splenic Ly6chiCCR2+ monocytes-CD45+, Singlets, CD115+, SSClo, 
Ly6chi; Neutrophils- Singlets, CD45+, CD11b+, Ly6g+. (D, E) Flow cytometric analysis of 
resident intestinal macrophages in Mecp2-null mice as compared to wild type control. (D) 
Representative flow cytometry plots showing the percentage of CD64+F4/80+ out of all 
CD45+ intestinal cells in pre- and late-phenotypic Mecp2-null mice as compared to age-matched 
wild type controls. (E) Quantification of CD64+CD11b+ intestinal macrophages as measured by 
both percentage of total live intestinal cells (Two-way ANOVA with Bonferroni post-test; **, p < 
0.01; ***, p < 0.001) and absolute cell counts per animal (Two-way ANOVA with Bonferroni 
post-test; **, p < 0.01; ***, p < 0.001). Data is representative of two independent experiments for 
phenotypic mice. Data are presented as mean ±SEM. (F) Flow cytometry plots of 
Ly6chiCCR2+ and Ly6clo blood monocytes in pre- and late-phenotypic Mecp2-null mice as 
compared to age-matched wild type controls. Numbers represent percentage of cells out of 
Singlets, Live, CD45+CD11b+Ly6g−CD115+SSClo monocytes. (G) Quantification of numbers of 
circulating Ly6chiCCR2+ and Ly6clo monocytes (*, p<0.05; **, p<0.01; Two-way ANOVA with 
Bonferroni post-test; n = 6–8 mice per group. Error bars represent SEM). (H) Representative 
plots of CD11b+CD115+ total monocytes from blood of wild type and Mecp2-null mice on day 5 
post clodronate liposome injection. (I) Monocyte count from peripheral blood of Mecp2-null and 
wild type controls on day 5 post clodronate liposome injection (unpaired two-tailed Student’s t-
test, not significant. Error bars represent SEM). (J) Representative flow cytometry plots 
displaying differentiation of Ly6chiCCR2+ monocytes to Ly6clo monocytes and quantification of 
%Ly6cloCCR2− resident monocytes on day 5 post clodronate liposome injection; representative of 
two independent experiments. (***, p<0.001, unpaired two-tailed Student’s t-test. Error bars 
represent SEM). (K) Same as (J), except only DiI+ monocytes are shown (cells labeled on day 2 
post clodronate injection via DiI liposome injection); representative of two independent 
experiments. ***, p<0.001 (unpaired two-tailed Student’s t-test. Error bars represent SEM). 
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Figure II-4 Postnatal expression of Mecp2 viaCx3cr1creER in otherwise Mecp2-deficient mice 
increases lifespan. 
(A) Cx3cr1creER/+Mecp2Lox-stop/y mice after postnatal tamoxifen or oil control treatment in 
phenotypic mice (**, p<0.01; log-rank Mantel-Cox test; tamoxifen treated n = 8, oil treated n = 
12). (B) Weight change after postnatal tamoxifen or oil control treatment in 
phenotypic Cx3cr1creER/+Mecp2Lox-stop/y mice (**, p < 0.01; ***, p<0.001. Two-way ANOVA with 
Bonferroni post-test; n = 5 oil and n = 3 tamoxifen treated Cx3cr1creER/+Mecp2Lox-stop/y. n = 
7 Cx3cr1creER/+Mecp2+/y tamoxifen treated. Asterisks over Cx3cr1creER/+Mecp2Lox-stop/y oil-treated 
indicate comparisons to Cx3cr1creER/+Mecp2Lox-stop/y tamoxifen-treated. Asterisks 
over Cx3cr1creER/+Mecp2Lox-stop/y tamoxifen-treated indicate comparisons to Cx3cr1creER/+Mecp2+/y. 
Data are presented as mean ± SEM). (C-G) Analysis of Mecp2 re-expression in tamoxifen treated 
mice. Mice were fed tamoxifen food for 3 months to maximize possible recombination and 
analyzed by flow cytometry. Flow cytometry plots displaying Mecp2 expression 
in Cx3cr1creER/+Mecp2Lox-stop/y mice with or without tamoxifen treatment in (C) circulating 
monocytes, B, and T cells; (D) red pulp macrophages; (E) intestinal macrophages; (F) microglia 
and (G) total non-microglia nucleated cells in the CNS.
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Figure II-5 Mecp2 regulates glucocorticoid and hypoxia responses in microglia and 
peritoneal macrophages.  
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Scatter plot comparing global gene expression profiles between wild type and Mecp2-null 
microglia. The black lines indicate a 2-fold cut-off for the difference in gene expression levels. 
Data represent the average of 6 wild type and 3 Mecp2-null samples, with each sample 
representing 3 pooled mice (thus, 18 mice and 9 mice respectively). mRNA expression is shown 
on a log2 scale. (B) Gene set enrichment analysis (GSEA) reveals the over-representation of 
glucocorticoid transcription signature genes in Mecp2-null microglia. The middle part of the plot 
shows the distribution of the genes in the glucocorticoid transcription signature gene set (‘Hits’) 
against the ranked list of genes. Data represent the average of 6 wild type and 3 Mecp2-null 
samples. (C) Scatter plot comparing global gene expression profiles between wild type and 
Mecp2-null peritoneal macrophages as in (A). Data represent the average of 6 pooled wild type 
and 6 pooled Mecp2-null mice. (D) Global gene expression in wild type and Mecp2-null 
peritoneal macrophages was analyzed as in (B). Data represent the average of 6 pooled wild type 
and 6 pooled Mecp2-null mice. (E) ChIP of Mecp2 from unstimulated wild type macrophages 
showing binding of Mecp2 to the promoter region of the Fkbp5 gene. Data were normalized to 
IgY (negative control). Data represent the average of three independent experiments. *** p < 
0.001 and ** p < 0.01, (unpaired two-tailed Student’s t-test. Data are presented as mean ±SEM). 
(F) ChIP analysis of histone H4 acetylation at the Fkbp5 gene promoter in wild type and Mecp2-
null macrophages. Data represent the average of three independent experiments (*** p < 0.001 
and ** p < 0.01; unpaired two-tailed Student’s t-test. Data are presented as mean ± SEM). (G) 
Dexamethasone-stimulation of wild type and Mecp2-null macrophages was associated with a 
significant increase in Fkbp5 mRNA levels. Dexamethasone induction of Fkbp5 mRNA was 
significantly increased in Mecp2-null macrophages. Data represent the average of three 
independent experiments (*** p < 0.001 and ** p < 0.01; unpaired two-tailed Student’s t-test. 
Data are presented as mean ± SEM). (H) Scatter plot comparing global gene expression profiles 
between wild type and Mecp2-null microglia. The black lines indicate a 2-fold cut-off for the 
difference in gene expression levels. Data represent the average of 6 wild type and 3 Mecp2-null 
samples, with each sample representing 3 pooled mice (18 and 9 mice respectively). mRNA 
expression levels are on a log2 scale. (I) Gene-set enrichment analysis (GSEA) reveals the over-
representation of hypoxia signature genes in unstimulated Mecp2-null microglia. (J) Wild type 
and Mecp2-null macrophages were grown in hypoxia or normoxia for 24 hrs. mRNA levels 
of Hif3a Ddit4, and Cyr61 were measured using qRT-PCR. Results are representative of three 
independent experiments (average of three values  ±  SEM; *** p < 0.001 by unpaired two-tailed 
Student’s t-test). 
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Figure II-6 Mecp2 restrains inflammatory responses in macrophages.  
(A) Wild type and Mecp2-null macrophages were treated for 6 hr with TNF and subjected to 
quantitative real time PCR (qRT-PCR) for Tnf Il6 Cxcl2 Cxcl3, and Csf3. Data are representative 
of three experiments (average of three values ± SEM; ***, p < 0.001 and ** p < 0.01; Two-way 
ANOVA with Bonferroni post-test). (B) Mecp2-null or age-matched wild type mice were injected 
with intraperitoneal TNF and allowed to respond for 6 hr. Resident peritoneal macrophages were 
collected by lavage and subsequent AutoMACS sort for F4/80+ cells. RNA was collected and 
qRT-PCR performed for the indicated genes (*, p < 0.05; Two-way ANOVA with Bonferroni 
post-test. Interaction for Genotype and Gene; *, p = 0.01. N = 3 wild type and 4 Mecp2-null. Data 
are presented as mean ± SEM). (C) Granulocyte colony-stimulating factor (GCSF) ELISA of 
serum from late-phenotypic Mecp2-null mice and wild type controls (*, p < 0.05; Mann-Whitney 
two-tailed; n = 9 per group. Data are presented as mean ± SEM). (D) Representative flow 
cytometry plots of Mecp2-null and wild type mice treated with anti-GCSF neutralizing or isotype 
antibodies showing percentage of neutrophils out of all CD45+ circulating blood cells. Plots are 
representative of two independent experiments performed with n = 2 mice for all groups, 
analyzed 1–2 weeks post start of injections. (E) Survival of Mecp2-null mice treated with either 
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anti-GCSF neutralizing or isotype antibodies (*, p < 0.05; log-rank Mantel-Cox test; n = 11 per 
group).
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Chapter III Unexpected role of interferon-γ in regulating neuronal 
connectivity and social behavior 
Summary  
Immune dysfunction is commonly associated with several neurological and 
mental disorders. Although the mechanisms by which peripheral immunity may 
influence neuronal function are largely unknown, recent findings implicate 
meningeal immunity influencing behaviour, such as spatial learning and memory 
(Derecki et al., 2010). Here we show that meningeal immunity is also critical for 
social behaviour; mice deficient in adaptive immunity exhibit social deficits and 
hyper-connectivity of fronto-cortical brain regions. Associations between rodent 
transcriptomes from brain and cellular transcriptomes in response to T-cell-
derived cytokines suggest a strong interaction between social behaviour and 
interferon-gamma (IFN-γ)-driven responses. Concordantly, we demonstrate that 
inhibitory neurons respond to IFN-γ and increase GABAergic (γ-aminobutyric-
acid) currents in projection neurons, suggesting that IFN-γ is a molecular link 
between meningeal immunity and neural circuits recruited for social behaviour. 
Meta-analysis on the transcriptomes of a range of organisms reveals that 
rodents, fish, and flies elevate IFN-γ/JAK-STAT-dependent gene signatures in a 
social context, suggesting that the IFN-γ signalling pathway could mediate a co-
evolutionary link between social/aggregation behaviour and an efficient anti-
pathogen response. This study implicates adaptive immune dysfunction, in 
particular IFN-γ, in disorders characterized by social dysfunction and suggests a 
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co-evolutionary link between social behaviour and an anti-pathogen immune 
response driven by IFN-γ signalling. 
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Methods 
Mice 
All mice (C57BL/6) were either bred in-house or purchased from the Jackson 
Laboratory. For each individual experiment, the control mice were obtained from 
the same institution as test mice. In the case that mice were purchased, they 
were maintained for at least 1 week to habituate before 
manipulation/experimentation. When possible, mice used for experiments were 
littermates. These include all electrophysiology experiments, all cohorts using 
Stat1fl/fl mice, experiments analysing induced seizures, experiments counting c-
fos+ neurons, and experiments using Il4–/– mice. Experiments assessing the 
social behaviour of SCID mice using the three-chamber assay included mice 
bred in-house and mice purchased from the Jackson Laboratory. All other 
experiments used mice purchased from the Jackson Laboratory. Experimental 
groups were blinded and randomly assigned before the start of experimentation 
and remained blinded until all data were collected. Mice were housed under 
standard 12 h light/dark cycle conditions in rooms equipped with control for 
temperature and humidity. Unless stated otherwise, male mice were tested at 8–
10 weeks of age. Sample sizes were chosen on the basis of a power analysis 
using estimates from previously published experiments. All experiments were 
approved by the Institutional Animal Care and Use Committee of the University of 
Virginia. 
 
 52 
 
Behaviour 
For cohorts tested with multiple behavioural assay, the elevated plus-maze was 
performed first and then followed by the open field before any other assay. 
Before all experiments, mice were transported to the behaviour room and given 1 
h to habituate. All behavioural testing was conducted during daylight hours. 
Elevated plus-maze 
Mice were placed into the centre hub and allowed to explore the plus-maze for 
10 min. Video tracking software (CleverSys) was used to quantify time spent in 
the open arms. 
Open field 
Mice were placed into the open field (35 cm × 35 cm) and allowed to explore for 
15 min. Total distance and time spent in the centre (23 cm × 23 cm) were 
quantified using video tracking software (CleverSys). 
Rotarod 
Mice were placed on an accelerating rotarod (MedAssociates) that accelerated 
from 4.0 to 40 rpm over 5 min. Infrared beams were used to quantify the latency 
of a mouse to fall off the rod. Mice were given six trials with a 4-h break between 
trials 3 and 4. 
Three-chamber sociability assay 
The three-chamber sociability test was conducted as previously described (Moy 
et al., 2004). Briefly, mice were transported to the testing room and habituated for 
at least 1 h. The room was maintained in dim light and a white noise generator 
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used to mitigate any unforeseen noises. Test boxes were fabricated, in-house, by 
a machine shop. Test mice were placed in the centre chamber with the two outer 
chambers containing empty wire cages (Spectrum Diversified Designs) and 
allowed to explore for 10 min (habituation phase). After the habituation phase, 
mice were returned to the centre chamber. A novel mouse (an 8- to 10-week-old 
male C57BL/6J, ~18–22g) was placed under one cup and an object placed under 
the other. Before testing, the novel mouse was habituated to the cup by being 
placed under the cup for 10 min, three times a day for 5 days. Mice were allowed 
to explore for an additional 10 min (social phase). A video tracking system 
(CleverSys) was used to quantify the time spent around each target. For three-
chamber experiments comparing social behaviour between wild-type and SCID 
mice, data collected using males and females were combined because no 
significant effects were found between genders. When females were tested, 
juvenile C57BL/6J male (approximately 4 weeks old) mice were used as novel 
demonstrators. 
Novel/social environment 
Mice were single housed and maintained unmanipulated for 5 days, then placed 
in a novel/social environment with a mouse (opposite sex and identical scid 
genotype) under video surveillance as previously described (Filiano et al., 2013). 
After 2 h, mice were killed and prepared for immunohistochemistry as described 
below. The time spent interacting was measured by a blinded observer for 5 min 
at the 30, 60, and 90 min post-introduction time points. 
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Resting-state fMRI 
The protocol for rsfMRI was adapted from Zhan et al. (Zhan et al., 2014). Mice 
were maintained under light anaesthesia with (1–1.25%) isoflurane and images 
were acquired on a 7.0 T MRI Clinscan system (Bruker, Etlingen, Germany) 
using a 30-mm inner-diameter mouse whole-body radiofrequency coil. High-
resolution structural images were acquired by collecting 16 0.7-mm-thick coronal 
slices using TR/TE 5,500/65 ms and an 180° flip angle. A BOLD rsfMRI time 
series of 16 0.7-mm-thick coronal slices was collected using TR/TE 4,000/17 ms 
and a 60° flip angle. For analysis, a structural template was custom labelled 
using The Mouse Brain by Paxinos and Franklin as reference (Johnson et al., 
2010). The non-rigid transformation between the template and each individual 
mouse was estimated using the open source Advanced Normalization Tools 
(ANTs) package that was then used to propagate the regional labels to each 
subject (Avants et al., 2011). Cleaning of the bold fMRI data was performed 
using tools available in ANTsR—a statistical and visualization interface between 
ANTs and the R statistical project (Avants et al., 2015). fMRI preprocessing 
consisted of motion correction (Power et al., 2012), bandpass filtering 
(frequency = 0.002–0.1) and CompCor estimation (Behzadi et al., 2007). The 
correlation matrix was determined from the clean fMRI data using the regions 
labels. To determine whether the functional connectivity between sample groups 
was significantly different, we tested for the equality of their corresponding 
correlation matrices. First, an aggregate correlation matrix was constructed for 
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each group by calculating the median value for each connection, and then the 
aggregate matrices were compared using the Jennrich test, as implemented in 
the cortest.jennrich function in the R psych package. To create a functional 
connectivity network for a sample group, a correlation threshold was applied to 
the connections between regions of interest. If a connection strength was above 
the threshold, it was kept as an edge in the network, otherwise it was discarded. 
When comparing networks from multiple sample groups, the threshold was 
determined by calculating the maximum threshold that left one of the networks 
connected (that is, it was possible to reach any node in the network from any 
other node). 
Immunohistochemistry 
Mice were killed under Euthasol then transcardially perfused with PBS with 
heparin. Brains were removed and drop fixed in 4% PFA for 48 h. After fixation, 
brains were washed with PBS, cryoprotected with 30% sucrose, then frozen in 
O.C.T. compound (Sakura Finetek) and sliced (40 µM) with a cryostat (Leica). 
Free-floating sections were maintained in PBS + Azide (0.02%) until further 
processing. Immunohistochemistry for c-fos (1:1,000 dilution; Millipore) on free-
floating sections was performed as previously described (Palop et al., 2011). 
Depletion of meningeal T cells 
A rat monoclonal antibody to murine VLA4 (clone PS/2) was affinity purified from 
hybridoma supernatants and was used with the permission of K. Ley (La Jolla 
Institute of Allergy and Immunology, San Diego, CA). Mice were given two 
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separate injections (intraperitoneal; 0.2 mg in saline per mouse), 4 days apart, of 
either anti-VLA4 or rat anti-HRP for control (clone HRPN; BioXcell), then tested 
24 h after final injection. 
Dissection of meninges and flow cytometry 
Meninges were dissected as previously described (Derecki et al., 2010). Briefly, 
after killing and perfusing, skulls caps were removed by making an incision along 
the parietal and squamosal bones. The meninges were removed from the 
internal side of the skull cap and gently pressed through a 70 µm nylon mesh cell 
strainer with sterile plastic plunger (BD Biosciences) to isolate a single cell 
suspension. Cells were then centrifuged at 300g at 4 °C for 10 min, resuspended 
in cold FACS buffer (pH 7.4; 0.1 M PBS; 1 mM EDTA; 1% BSA), and stained for 
extracellular markers using the following antibodies at a 1:200 dilution: CD45 
PerCP-Cyanine5.5 (eBioscience), TCR BV510 (BD Bioscience), CD4 FITC 
(eBioscience), L/D Zombie NIR (BioLegend). To measure intracellular IFN-γ 
single-cell isolates from meninges were maintained in T-cell isolation buffer 
(RPMI + 2% FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES, 1× 
non-essential amino acids, and 1× Antibiotic-Antimycotic (Thermo Fisher) and 
stimulated with PMA/ionomycin (Cell Stimulation Cocktail – eBioscience) + 10 
µg/ml brefeldin A at 37°C before extracellular staining as stated above. Cells 
were then permeabilized with Cytofix/Cytoperm (BD Biosciences) and stained 
with IFN-γ APC (eBioscience; clone XMG1.2). 
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To measure expression of IFN-γ receptors, brains were removed and 
placed in Neurobasal media containing 10% fetal bovine serum. The meninges 
were removed from the brain and the frontal cortex was micro-dissected under a 
dissection microscope. Using a 2 ml dounce homogenizer, brains were 
homogenized in Neurobasal media with 50 U/ml Dnase I. The homogenate was 
passed through a 70 µm nylon filter and washed with cold FACS buffer. IFNGR 
were labelled with anti-IFNGR1 Biotin (BD Pharmingen; GR20) or rabbit anti-
IFNGR2 (Santa Cruz; M-20). Cells were washed with FACS buffer and incubated 
with FITC conjugated streptavidin or 488 conjugated chicken anti-rabbit. Next, 
cells were washed again then incubated with CD11B PE-Cyanine7 
(eBioscience), L/D Zombie NIR (BioLegend), and Hoechst for 45 min. Cells were 
washed, then permeabilized and fixed with Cytofix/Cytoperm (BD Biosciences). 
After another wash with permeabilization wash buffer (PBS with 10% fetal bovine 
serum, 1% sodium azide, and 1% saponin; pH 7.4), cells were incubated 
overnight with NeuN PE (Millipore). Cells underwent a final wash and again 
passed through a 70 µm nylon filter. Samples were run on a flow cytometer 
Gallios (Beckman Coulter) then analysed using FlowJo software (Treestar). 
SCID repopulation 
SCID mice were repopulated with cells from spleen and lymph nodes (axillary, 
brachial, cervical, inguinal, and lumbar). Spleen and lymph nodes were collected 
from a 3- to 4-week-old donor and passed through a 70 µm nylon mesh cell 
strainer with a sterile plastic plunger. ACK buffer was used to lyse red blood cells 
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before washing with saline. Cells were counted on an automated cell counter 
(Nexcelom) and injected (intravenously) at 5 × 106 cells in 250 µl of saline 
(control mice were injected with 250 µl of saline only). For injections, the animal 
technician was blinded to the genotype of the mice and the content of the 
injection. Thus, all groups were handled identically. Mice aged 3–4 weeks were 
carefully placed into a tail vein injection platform. Their tails were briefly warmed 
using a heating pad and saline with cells or saline alone was slowly injected into 
the tail vein using a 28-gauge needle. After the injection, mice were returned to 
their home cage. 
IFN-γ injections 
Mice were anaesthetized with a ketamine/xylazine (ketamine (100 mg/kg) and 
xylazine (10 mg/kg)) injection (intraperitoneal) or isoflurane (2%), then placed 
into a stereotaxic frame with the head at an approximately 45° angle. The skin 
above the cisterna magna was cleaned and sanitized before a 1 cm incision was 
made. The underlying muscles were separated with forceps, retracted, and a 
small Hamilton syringe (33-gauge) was used to slowly inject 1 μl of saline or IFN-
γ (20 ng; eBioscience) into the cisterna magna. After injection the syringe was 
held in place for 5 min to avoid back-flow of CSF. After the syringe was removed, 
muscles were put back in place and skin was sutured. Mice were placed on a 
heating pad and given ketoprofen and baytril for recovery. 
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Induced seizures 
IFN-γ was injected into the CSF through the cisterna magna as described above, 
24 h before inducing seizures. Control mice were injected with the same volume 
of saline. To induce seizures, mice were injected with PTZ (40 mg/kg; 
intraperitoneally). After injection, mice were placed into an empty housing cage 
and recorded for video analysis. Seizures were analysed by a blinded observer 
using a behaviour scoring system previously published (Li et al., 2014b). 
Diazepam treatment 
Diazepam (1.25 mg/kg) was delivered intraperitoneal for 30 min before testing for 
social behaviour. 
Fluorescence in situ hybridization 
Mice were euthanized then transcardially perused with PBS with heparin followed 
by 4% PFA. Brains were then removed and drop fixed in 4% PFA for 24 h, frozen 
in OCT, and 12 µM sections were cut on a cryostat. Fluorescence in situ 
hybridization was performed using RNA ISH tissue assay kits (Affymetrix) 
following the manufacturer’s protocol. Tissues were treated with protease for 20 
min at 40 °C. Images at 63× magnification were acquired on a Leica TCS SP8 
confocal system (Leica Microsystems) using LAS AF Software. 
AAV delivery 
AAV1.hSyn.HI.eGFP–Cre.WPRE.SV40 and AAV1.hSyn.eGFP.WPRE.bGH were 
purchased from Penn Vector Core. IFNGR1fl/fl mice were purchased from the 
Jackson Laboratory. After 1 week of habituation, mice were anaesthetized with 
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2% isoflurane and injected bilaterally with 2 × 1010 genome copies of AAV virus 
in 1 µl at stereotaxic coordinates +2.5 µm bregma A/P, 0.25 µm lateral, 1.25 µm 
deep. 
Measuring inhibitory currents 
Visualized whole-cell patch-clamp recordings were performed on layer II/III 
prefrontal cortical neurons prepared from acute brain slices (adult) using the 
protective recovery method (Ting et al., 2014). Recordings were performed in 34 
°C artificial cerebrospinal fluid (ACSF) containing (in mM) 131.5 NaCl, 25 
NaHCO3, 12 D-glucose, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, and 1 MgCl2. ACSF 
also contained 3 mM kynurenic acid to block synaptic excitation and 2.5 mM NO-
711 to enhance tonic inhibition (Nusser and Mody, 2002). Slices were incubated 
in this ACSF for 5–10 min before placement in the recording chamber. The patch 
pipette solution with elevated chloride contained (in mM) 140 CsCl, 4 NaCl, 1 
MgCl2, 10 HEPES, 0.05 EGTA, 2 Mg-ATP, and 0.4 Mg-GTP. Once recordings 
equilibrated, baseline holding current in ACSF was measured for 3.5 min, after 
which ACSF containing IFN-γ (20 pg/ml) was applied for 8.5 min and then 
washed. Data presented show the mean holding current during the last minute of 
control (ACSF) and drug (ACSF + IFN-γ) conditions. 
RNA isolation and sequencing 
Eight-week-old male mice were purchased from the Jackson Laboratory and 
housed in standard housing boxes with either four mice per cage or isolated for 6 
days. Mice were euthanized as described above and the PFC was 
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microdissected under a dissection microscope. RNA was isolated using an 
RNAeasy mini kit (Qiagen) and a cDNA library was generated with a TruSeq 
Stranded mRNA Library Prep Kit (Illumina) with Agencourt AMPure XP beads for 
PCR cleanup. Samples were loaded onto a NextSeq 500 High-output 75 cycle 
cartridge and sequenced on a NextSeq 500 (Illumina). 
Transcriptome analysis 
Raw FASTQ sequencing reads were chastity filtered to remove clusters having 
outlying intensity corresponding to bases other than the called base. Filtered 
reads were assessed for quality using FastQC. Reads were splice-aware aligned 
to the UCSC mm9 genome using STAR (Dobin et al., 2013), and reads 
overlapping UCSC mm9 gene regions were counted using featureCounts (Liao et 
al., 2014b). The DESeq2 Bioconductor package (Love et al., 2014) in the R 
statistical computing environment was used for normalizing count data, 
performing exploratory data analysis, estimating dispersion, and fitting a negative 
binomial model for each gene comparing the expression from the PFC of mice in 
a social environment versus isolation. After obtaining a list of differentially 
expressed genes, log (fold changes), and P values, Benjamini–Hochberg false 
discovery rate procedure was used to correct P values for multiple testing. A 
gene set enrichment analysis (GSEA) algorithm (Subramanian et al., 2005) was 
applied to identify the enrichment of transcriptional signatures and molecular 
pathways in PFC transcriptomes of mice exposed to group and isolation housing 
conditions. Four thousand seven hundred and twenty-six publicly available 
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transcriptional signatures were obtained from the molecular Signature Database 
C2 version 4.0, and GSEA was used to examine the distribution of these curated 
gene sets in lists of genes ordered according to differential expression between 
group and isolation housing conditions. We analysed statistics by evaluating 
nominal P value and normalized enrichment score (NES) on the basis of 1,000 
random sample permutations. 
Meta-analysis 
The custom-made IFN-γ and pathogen-induced transcriptional signatures were 
generated by retrieving genes upregulated at least twofold following IFN-γ 
stimulation or pathogen infection. All custom signatures were derived from 
publicly available transcriptomes downloaded from Gene Expression Omnibus 
(GEO). Specifically, mammalian IFN-γ transcriptional signatures were derived 
from transcriptomes GSE33057, GSE19182, GSE36287, GSE9659, GSE1432, 
and GSE6353. Zebrafish IFN-γ transcriptional signature was used as described 
(Lopez-Munoz et al., 2009). Drosophila pathogen-induced JAK/STAT-dependent 
transcriptional signatures were derived from transcriptomes GSE54833 and 
GSE2828. 
A GSEA algorithm was applied to identify the enrichment of custom-made 
mammalian IFN-γ transcriptional signatures in the publicly available brain cortex 
transcriptomes of mice and rats exposed to social aggregation, sleep deprivation, 
stress, psychostimulants (DOI, cocaine, amphetamine, methamphetamine, 
methylphenidate, caffeine, nicotine, and modafinil), antipsychotics (olanzapine, 
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haloperidol, and risperidone), anticonvulsants (levetiracetam, phenytoin, 
ethosuximide, and oxcarbazepine), and antidepressants (iproniazid, 
moclobemide, paroxetine, and phenelzine). In total, 41 transcriptomes were 
analysed as indicated in Supplementary Table 2. We analysed statistics by 
evaluating nominal P value and NES on the basis of 1,000 random sample 
permutations. 
Zebrafish are social fish that aggregate into shoals (Engeszer et al., 2007, 
Krause et al., 2000, Miller and Gerlai, 2007, Saverino and Gerlai, 2008). Various 
zebrafish strains differ in their preference for social interaction and novelty, 
resembling the phenotypic variation of inbred mouse strains (Barba-Escobedo 
and Gould, 2012, Moy et al., 2004). Notably, domesticated zebrafish strains 
demonstrate higher social interaction and social novelty preference (Moretz et 
al., 2007, Zala et al., 2012) compared with wild zebrafish strains. Therefore, a 
GSEA algorithm was used to identify the enrichment of zebrafish IFN-γ 
transcriptional signature in the publicly available whole-brain transcriptomic 
profiles of behaviourally distinct strains of domesticated and wild zebrafish. The 
brain transcriptomic profiles of domesticated (Scientific Hatcheries (SH) and 
Transgenic Mosaic 1 (TM1)) and wild (Nadia, Gaighata) zebrafish strains were 
derived from publicly available transcriptome data set GSE38729. We analysed 
statistics by evaluating nominal P value and NES on the basis of 1,000 random 
gene set permutations. 
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Social interactions in Drosophila melanogaster flies play an important role 
in courtship, mating, egg-laying, circadian timing, food search, and even lifespan 
determination (Levine et al., 2002, Mery et al., 2009, Ruan and Wu, 2008, Sarin 
and Dukas, 2009, Sokolowski, 2010). Notably, a number of studies have 
demonstrated that social isolation leads to an aggressive behaviour in Drosophila 
flies, whereas group housing suppresses the aggressiveness (Hoffmann, 1987, 
Kamyshev et al., 2002, Wang et al., 2008). Therefore, we employed a GSEA 
algorithm to identify the enrichment of JAK/STAT-dependent transcriptional 
signatures in the publicly available brain transcriptomes of Drosophila 
populations that were socially-induced or genetically-selected for low-aggressive 
(that is, social) behaviour. The transcriptomic profiles were derived from publicly 
available transcriptome data sets GSE5404 and GSE6994. We analysed 
statistics by evaluating nominal P value and NES on the basis of 1,000 random 
gene set permutations. 
Promoter motif analysis 
A GSEA algorithm was used to identify genes that are differentially expressed in 
brain transcriptomes of mice and rats exposed to social aggregation, 
domesticated zebrafish strains, and low-aggressive Drosophila melanogaster 
populations, compared with their control counterparts. High-scoring differentially 
expressed ‘leading-edge’ social genes were selected on the basis of their 
presence in the IFN-γ and pathogen-induced transcriptional signatures. 
Specifically, as shown in Figure III-3, we have identified 31, 48, 14, and 53 
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leading-edge genes in brain transcriptomes of mice and rats exposed to social 
aggregation, domesticated Zebrafish strain, and low-aggressive Drosophila 
melanogaster population, respectively. We next extracted promoter sequences of 
200 bp upstream of transcription start sites of these ‘leading-edge’ genes using 
UCSC Genome Browser (https://genome.ucsc.edu/). The MEME suite was then 
used to discover overrepresented transcription factor binding motifs, as 
described (Bailey et al., 2009). MEME parameters used were any number of 
motif repetitions per sequence, with a minimum motif width of 5 bases and 
maximum motif width of 15 bases. The discovered MEME motifs were compared 
using Tomtom analysis. In this case, the Tomtom motif similarity analysis ranks 
the MEME motif most similar to the vertebrates in vivo and in silico. The statistics 
were determined using Euclidean distance. 
Circos plot 
A GSEA algorithm was applied to identify the enrichment of IFN-γ, IL-4/IL-13, IL-
17, and IL-10/TGF-β signalling pathways in the brain transcriptomes of rodent 
animals exposed to social aggregation, stress, psychostimulants, antipsychotics, 
and antidepressants. All custom signatures were derived from publically available 
rodent transcriptomes downloaded from Gene Expression Omnibus. Statistical 
significance of GSEA results was assessed using 1,000 sample permutations. A 
NES greater than 1.5 and a nominal P value less than 0.05 was used to 
determined pairwise transcriptome connectivity. A Circos graph was generated 
using circos package 0.68.12 (Krzywinski et al., 2009). 
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Statistics 
Data were analysed using the statistical methods stated in each figure legend. 
For the three-chamber assay, a two-way ANOVA was performed using 
genotype/treatment and sociability as main effects, followed by applying a 
Sidak’s post hoc comparison to assess if the group had a significant social 
preference. Before running an ANOVA, an equality of variance was determined 
by using a Brown–Forsythe test. Bars display the means, and error bars 
represent ranges of the standard error of the mean. For rsfMRI, data were 
analysed using a one-way ANOVA followed by a post hoc Tukey’s test. The box 
and whisker plots extend to the 25th and 75th percentiles and the centre line 
indicates the mean. The whiskers represent the min and max data points. Data 
for seizure latency were analysed using a two-way ANOVA with repeated 
measures followed by Sidak’s post hoc test.  
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Results 
Meningeal T-cell compartment is necessary for supporting neuronal 
connectivity and social behaviour 
Social behaviour is beneficial for many processes critical to the survival of an 
organism, including foraging, protection, breeding, and, for higher-order species, 
mental health (Cacioppo et al., 2014, Bourke, 2014). Social dysfunction 
manifests in several neurological and mental disorders such as autism spectrum 
disorder, frontotemporal dementia, and schizophrenia among others (Kennedy 
and Adolphs, 2012). Likewise, imbalance of cytokines, a disparity of T-cell 
subsets, and overall immune dysfunction is often associated with the above-
mentioned disorders (Ashwood et al., 2011, Gupta et al., 1998, Waisman et al., 
2015). However, the fundamental mechanisms by which dysfunctional immunity 
may interfere with neural circuits and contribute to behavioural deficits remain 
unclear. 
To test whether adaptive immunity is necessary for normal social 
behaviour, we tested SCID mice (deficient in adaptive immunity) using the three-
chamber sociability assay (Moy et al., 2004). This assay quantifies the 
preference of a mouse for investigating a novel mouse versus object, and has 
been used to identify deficits in multiple mouse models of disorders that present 
with social dysfunction (Silverman et al., 2010). Unlike wild-type mice, SCID mice 
lacked social preference for a mouse over an object (Figure III-1a). Importantly, 
SCID mice did not show anxiety, motor, or olfactory deficits. We confirmed that 
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SCID mice have social deficits by analysing social interactions in a home cage 
(data not shown). To test whether social deficits were reversible, we repopulated 
4-week-old SCID mice with wild-type lymphocytes and measured social 
behaviour 4 weeks after transfer. SCID mice repopulated with lymphocytes, 
unlike those injected with the vehicle, showed social preference indistinguishable 
from wild-type mice (Figure III-1b). 
Recent clinical findings indicate disturbed circuit homeostasis, resulting in 
hyper-connectivity, is a feature of children with autism spectrum disorder (Nelson 
and Valakh, 2015). Imaging studies using task-free resting state fMRI (rsfMRI), 
revealed hyper-connectivity among frontal cortical nodes in patients with autism 
spectrum disorder (Supekar et al., 2013). Disturbances in resting state 
connectivity are also observed in mice with social deficits (Zhan et al., 2014). 
rsfMRI is an unbiased technique used to assess synchrony between brain 
regions over time by comparing spontaneous fluctuations in blood oxygenation 
level-dependent (BOLD) signals (Shen, 2015). To assess the influence of 
adaptive immunity on functional connectivity, we analysed resting-state BOLD 
signals from wild-type and SCID mice. SCID mice exhibited hyper-connectivity 
between multiple frontal and insular regions (Figure III-1c and 1d) implicated in 
social behaviour and autism spectrum disorder. Notably, repopulating SCID mice 
with lymphocytes rescued aberrant hyper-connectivity observed in vehicle-
treated SCID controls (Figure III-1c and 1d). Interestingly, other functionally 
connected regions, not directly implicated in social function, such as 
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interhemispheric connectivity between motor and somatosensory cortex, were 
not affected by a deficiency in adaptive immunity. Using another approach to 
analyse neuronal activation in a task-based system, we demonstrated that SCID 
mice exposed to a social stimulus exhibited hyper-responsiveness in the 
prefrontal cortex (PFC; increased number of c-fos+ cells in PFC; Figure III-1e and 
1f) but not the hippocampus. 
 We previously demonstrated that T cells influence learning behaviour and 
exert their beneficial effects presumably from the meninges (Brynskikh et al., 
2008, Derecki et al., 2010) To address the role of meningeal T cells in social 
behaviour, we decreased the extravasation of T cells into the meninges of wild-
type mice using antibodies against VLA4 (Yednock et al., 1992), an integrin 
expressed on T cells (among other immune cells) required for CNS homing. 
Partial elimination of T cells from meninges was sufficient to cause a loss in 
social preference (Figure III-1g) . Despite their proximity to the brain, meningeal 
T cells do not enter the brain parenchyma, suggesting their effect is mediated by 
soluble factors. To identify which T-cell-mediated pathways are involved in 
regulating social behaviour, we used gene set enrichment analysis (GSEA) to 
search for T-cell-mediated response signatures (IFN-γ, IL-4/IL-13, IL-17, Il-10, 
TGF-β) in 41 transcriptomes from mouse and rat brain cortices. GSEA assesses 
whether the expression of a previously defined group of related genes is 
enriched in one biological state. In this case, we used GSEA to identify which 
cytokine-induced response signatures were enriched in the transcriptomes of 
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mice and rats exposed to different stimuli. The stimuli included social 
aggregation, sleep deprivation, stress, psychostimulants, antidepressants, 
anticonvulsants, and antipsychotics. Transcriptomes from cortices of animals 
exposed to social aggregation and psychostimulants were enriched for IFN-γ 
regulated genes (Figure III-1h). 
 
IFN-γ supports proper neural connectivity and social behaviour 
A substantial number of meningeal T cells are capable of expressing IFN-γ 
(41.95% ± 6.34 of TCR+ cells) and recent work has proposed a role for IFN-γ in 
T-cell trafficking into meningeal spaces (Kunis et al., 2013). To assess the 
potential role of IFN-γ in mediating the influence of T cells on social behaviour, 
we first examined the social behaviour of IFN-γ-deficient mice and determined 
that they had social deficits (Figure III-2a). Importantly, IFN-γ-deficient mice did 
not show anxiety or motor deficits (data not shown). Similar to SCID mice, IFN-γ-
deficient mice also exhibited aberrant hyper-connectivity in fronto-cortical/insular 
regions (Figure III-2b and 2c). While repopulating SCID mice with lymphocytes 
from wild-type mice restored a social preference, repopulating SCID mice with 
lymphocytes from Ifng–/– mice did not have such an effect (data not shown). 
Remarkably, a single injection of recombinant IFN-γ into the cerebrospinal fluid 
(CSF) of Ifng–/– mice was sufficient to restore their social preference when tested 
24 h after injection (Figure III-2d) and reduce overall hyper-connectivity in the 
PFC (data not shown). To further validate a role for IFN-γ signalling in social 
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behaviour, we tested mice deficient for the IFN-γ receptor (Ifngr1–/– mice) and 
found that they had a similar social deficit as Ifng–/– mice (data not shown), which, 
as expected, was not rescued by injecting recombinant IFN-γ into the CSF (data 
not shown). On the basis of our previous demonstration of a role for IL-4 
produced by meningeal T cells in spatial learning behaviour (Filiano et al., 2016), 
we assessed whether deficiency in IL-4 would also result in social deficits. IL-4-
deficient mice did not demonstrate social deficits; in fact, they spent more time 
investigating a novel mouse than a novel object compared with wild-type mice 
(data not shown). 
 To determine which cell types in the brain responding to IFN-γ, we 
analysed mouse PFC for the expression of IFN-γ receptor subunits 1 and 2 and 
found that both neurons and microglia express mRNA and protein for R1 and R2 
subunits of the IFN-γ receptor (Figure III-2e and 2f). Microglia are CNS resident 
macrophages and are known to express the IFN-γ receptor (Prieto et al., 1994). 
However, genetically deleting STAT1, the signalling molecule downstream of the 
IFN-γ receptor, from microglia (and other cells of myeloid origin), did not disturb 
normal social preference (data not shown). These results led us to focus on 
neuronal responses to IFN-γ as they relate to social behaviour. 
 To directly assess if IFN-γ can drive inhibitory tone in the PFC, we 
measured inhibitory currents in layer II/III pyramidal cells from acutely prepared 
brain slices from wild-type mice. In addition to receiving phasic inhibitory synaptic 
input, these cells are also held under a tonic GABAergic current that serves to 
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hyperpolarize their resting membrane potential (Figure III-2i). Tonic GABAergic 
currents are extra-synaptic and can yield long-lasting network inhibition (Olah et 
al., 2009). We observed that IFN-γ augmented tonic current (Figure III-2i and 2j), 
suggestive of elevated levels of ambient GABA during application of IFN-γ. 
Deleting the IFN-γ receptor from inhibitory neurons (VgatCre::Ifngr1fl/fl mice) 
prevented IFN-γ from augmenting tonic inhibitory current. Given that IFN-γ 
promotes inhibitory tone, we tested whether IFN-γ could prevent aberrant neural 
discharges by injecting IFN-γ into the CSF and then chemically inducing seizures 
with the GABA type A receptor antagonist pentylenetetrazole (PTZ). Mice 
injected with IFN-γ were less susceptible to PTZ-induced seizures: IFN-γ delayed 
seizure onset and lowered seizure severity (Figure III-2k). Further, to test 
whether over-excitation causes social deficits in IFN-γ-deficient mice, we treated 
Ifng–/– mice with diazepam to augment GABAergic transmission20. Diazepam 
successfully rescued social behaviour of Ifng–/– mice, similar to the effect 
observed with recombinant IFN-γ treatment (Fig III. 2l), suggesting that social 
deficits, caused by a deficiency in IFN-γ, may arise from inadequate control of 
GABAergic inhibition by IFN-γ. 
 
IFN-γ transcriptional signature genes in social behaviour-associated brain 
transcriptomes of rat, mouse, zebrafish, and Drosophila 
It is intriguing that IFN-γ, predominately thought of as an anti-pathogen cytokine, 
can play such a profound role in maintaining proper social function. Since social 
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behaviour is crucial for the survival of a species and aggregation increases the 
likeliness of spreading pathogens, we hypothesized that there was co-
evolutionary pressure to increase an anti-pathogen response as sociability 
increased, and that the IFN-γ pathway may have influenced this co-evolution. To 
test this hypothesis, we analyzed metadata of publically available transcriptomes 
from multiple organisms including the rat, mouse, zebrafish, and fruit flies. Using 
GSEA, we determined that transcripts from social rodents (acutely group-
housed) are enriched for an IFN-γ responsive gene signature (Figure III-3a and 
3b). Conversely, rodents that experienced social isolation demonstrated a 
dramatic loss of the IFN-γ responsive gene signature. Zebrafish and flies showed 
a similar association between anti-pathogen and social responses (Figure III-3c 
and 3d). We observed that immune response programs were highly enriched in 
the brain transcriptomes of flies selected for low aggressiveness traits (a 
physiological correlate for socially experienced flies; Figure III-3d). We next 
analyzed the promoters of these highly upregulated social genes and found them 
to be enriched for STAT1 transcription factor binding motifs (Figure III-3a−d). 
These data suggest, even in the absence of infection, an IFN-γ gene signature is 
upregulated in aggregated organisms. This is consistent with an interaction 
between social behaviour and the anti-pathogen response, a dynamic that could 
be mediated by the IFN-γ pathway. Since low-aggressive flies upregulate genes 
in the JAK/STAT pathway (canonically downstream of IFN-γ receptors in higher 
species), yet lack IFN-γ or T cells, it is intriguing to speculate that T-cell-derived 
 74 
 
IFN-γ may have evolved in higher species to more efficiently regulate an anti-
pathogen response during increased aggregation of individuals. 
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Figure III-1 Meningeal T cell compartment is necessary for supporting neuronal 
connectivity and social behavior.  
a, Wild-type mice exhibit social preference that is absent in SCID mice (ANOVA for genotype 
(F(1, 26)) = 6.370, P = 0.0181; n = 14 mice per group; **P < 0.01 Sidak’s post-hoc; pooled 2 
independent experiments). b, Repopulating the adaptive immune system in SCID mice restored 
normal social behavior (n = 17;16;15 mice per group; ANOVA for genotype (F(2, 45)) = 8.282, P 
= 0.0009 and interaction (F(2, 45)) = 9.146, P = 0.0005; ***P < 0.001; **P < 0.01 Sidak’s post-
hoc; pooled 3 independent experiments). c, Correlation matrices from wild-type, SCID, and 
repopulated (Repop.) SCID mice were generated by rsfMRI. Abbrev.: L=left; R=right; 
FrA=frontal association area; PrL=prelimbic cortex; Ins=insula; OrbC=orbital cortex. d, 
Correlation values from rsfMRI. The box and whisker plots extend to the 25th and 75th 
percentiles with the center-line showing the mean. The whiskers represent the min and max data 
points. (n = 8;9;4 mice per group; ANOVA < 0.05; *P < 0.05 Sidak’s post-hoc; pooled 2 
independent experiments). e, Immunohistochemistry of c-fos in the PFC. f, Elevated c-fos+ cells 
in the prefrontal and orbital cortices of SCID compared to wild-type mice (n = 9;10 mice per 
group; **P < 0.01; *P < 0.05 t-test; single experiment). g, Acute partial depletion of meningeal T 
cells caused social deficits (n = 12;13 mice per group; ANOVA for interaction (F (1, 23)) = 
7.900, P < 0.01; ***P < 0.001 Sidak’s post-hoc; pooled 2 independent experiments). h, Circos 
plot showing the connectivity map derived from the pairwise comparison of transcriptome 
datasets. IFN-γ signature genes are over-represented in cortex of animals exposed to social 
aggregation and psychostimulants. The representations of IFN-γ, IL-4/IL-13, IL-17, and IL-
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10/TGF-β dataset connectivity are shown in orange, green, blue, and purple, respectively. Each 
line represents a pairwise dataset overlap, which was determined using GSEA analysis and 
filtered by P < 0.05 and NES > 1.5. See for labels. Data from the 3-chamber test (a, b, g) were 
analyzed by applying a 2-way ANOVA for social behavior and genotype/treatment, followed by a 
post-hoc Sidak’s test. Bars represent average mean times investigating ± s.e.m. 
 77 
 
 
 
Figure III-2 IFN-γ supports proper neural connectivity and social behavior.  
a, Ifng−/− mice exhibit social deficits (n = 16;12 mice per group; ANOVA for genotype (F(1, 52)) 
= 8.327, P < 0.01; **P < 0.01 Sidak’s post-hoc; pooled 2 independent 
experiments). b, Correlation matrix from Ifng+/+ and Ifng−/− mice. c, Box and whisker plots of 
correlation values (n = 8 mice per group; *P < 0.05; # P = 0.06 t-test; repeated 2 times). d, A 
single CSF injection of IFN-γ (20ng) was sufficient to rescue social deficits in Ifng−/− mice 24 
hours post-injection (n = 14;11 mice per group; ANOVA for interaction (F (1, 46)) = 10.22 P < 
0.01; ***P < 0.001 Sidak’s post-hoc; pooled 2 independent experiments). e, Expression of IFN-γ 
receptor subunit mRNA by fluorescent in situ hybridization in slices from mouse PFC. RNA 
probes and corresponding colors: left:psd95-blue (neurons); right: CD11B-blue (microglia); top: 
IFNGR1-red; bottom: IFGR2-red. Yellow arrowheads denote co-localization. f, Expression of 
IFN-γ receptor subunit protein by flow cytometry. Cells were gated on Hoechst+/live/single then 
neurons and microglia were gated on NeuN and CD11B, respectively. Ifngr1−/− mice and no 
primary antibody for IFNGR2 were included as negative controls. g, Deleting Ifngr1from neurons 
in the PFC caused social deficits. Ifngr1fl/fl mice were injected with AAV-Syn-CRE-GFP into the 
PFC and tested for social behavior 3 weeks post injection (n = 11;12 mice per group; ANOVA for 
genotype (F (1, 21)) = 10.62, P < 0.01; *P < 0.05 Sidak’s post-hoc; pooled 3 independent 
experiments). h, VgatCre::Stat1fl/fl mice exhibit social deficits (n = 10;11 mice per group; ANOVA 
for interaction (F(1, 19)) = 10.30 < 0.01; ***P < 0.001 Sidak’s post-hoc; pooled 3 independent 
experiments). i, Layer 2/3 neurons in slices from wild-type mice are held under tonic GABAergic 
inhibition (top), which is blocked by the GABA-A receptor antagonist bicuculline. IFN-γ 
increases tonic GABAergic inhibitory current (n = 11 cells from 4 mice; bottom). j, Holding 
current pre and during IFN-γ (P = 0.01 t-test). k, IFN-γ increased latency to reach each seizure 
stage (n = 6 mice per group; ANOVA with repeated measures < 0.001; ***P < 0.001 Sidak post-
hoc) and (inset) reduced the maximum severity of seizures (***P < 0.001 t-test; repeated 2 
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times). l, Diazepam rescued social deficits in Ifng−/− mice (n = 12 mice per group; ANOVA for 
interaction (F (1, 22)) = 9.204 < 0.01; **P < 0.01 Sidak’s post-hoc; repeated 2 times). Data from 
the 3-chamber test (a, d, g, h, i) were analyzed by applying a 2-way ANOVA for social behavior 
and genotype/treatment, followed by a Sidak’s post-hoc test. Bars represent average mean times 
investigating ± s.e.m. All experiments were repeated at least once. 
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Figure III-3 Over-representation of IFN-γ transcriptional signature genes in social 
behavior-associated brain transcriptomes of rat, mouse, zebrafish, and drosophila.  
GSEA plots demonstrate the over-representation of IFN-γ transcriptional signatures (derived from 
Molecular Signature Database C2, GSE33057, or Lopez-Munoz, A. et al) in brain transcriptomes 
of (a) mice and (b) rats subjected to social or isolated housing and in brain transcriptomes of (c) 
domesticated zebrafish compared to a wild zebrafish strain. (d) Over-representation of 
JAK/STAT pathway transcriptional signature genes (derived from GSE2828) in head 
transcriptomes of flies selected for low-aggressive behavior (behavioral readout for social 
behavior in flies (see methods section “Meta-data analysis” for more details)). Genes are ranked 
into an ordered list according to their differential expression. The middle part of the plot is a bar 
code demonstrating the distribution of genes in the IFN-γ transcriptional signature gene set 
against the ranked list of genes. The list on the right shows the top genes in the leading-edge 
subset. Promoter regions of these genes were scanned for transcription factor binding site (TFBS) 
using MEME suite. MEME output demonstrates significant STAT TFBS enrichment in cis-
regulatory regions of leading edge genes up-regulated in a social context. 
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CHAPTER IV THE TREM2-APOE PATHWAY DRIVES THE 
TRANSCRIPTIONAL PHENOTYPE OF DYSFUNCTIONAL 
MICROGLIA IN NEURODEGENERATIVE DISEASES 
 
Summary 
Microglia play a pivotal role in the maintenance of brain homeostasis, but lose 
their homeostatic function during the course of neurodegenerative disorders. We 
identified a specific APOE-dependent molecular signature in microglia isolated 
from mouse models of amyotrophic lateral sclerosis, multiple sclerosis and 
Alzheimer’s disease (SOD1, EAE and APP-PS1) and in microglia surrounding 
neuritic Aβ-plaques in human Alzheimer’s disease brain. This is mediated by a 
switch from a (M0)-homeostatic to (MGnD)-neurodegenerative phenotype 
following phagocytosis of apoptotic neurons via the TREM2-APOE pathway. 
TREM2 induces APOE signaling which is a negative regulator of the transcription 
program in M0-homeostatic microglia. Targeting the TREM2-APOE pathway 
restores the M0-homeostatic signature of microglia in APP-PS1 and SOD1 mice 
and prevents neuronal loss in an acute model of neurodegeneration. Taken 
together, our work identifies the TREM2-APOE pathway as a major regulator of 
microglial functional phenotype in neurodegenerative diseases and serves as a 
novel target to restore homeostatic microglia. 
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Introduction 
Neuronal injury and cell death are common hallmarks of neurodegenerative 
processes (Mattson et al., 1998). It remains unclear whether neuronal cell death 
is a cause or result of Alzheimer’s disease (AD), especially when one considers 
that neurodegeneration is not an acute and rapid event but occurs gradually over 
a long period of time. However, apoptosis, as well as neuritic dystrophy leading 
to permanent central nervous system (CNS) damage, occurs in 
neurodegenerative diseases, including AD (Masliah et al., 1998) and 
amyotrophic lateral sclerosis (ALS) (Kostic et al., 1997), and in inflammatory 
autoimmune diseases such as multiple sclerosis (MS) (Ofengeim et al., 2015). 
Microglia are brain-resident immune cells that maintain CNS homeostasis, 
constantly survey their environment (Nimmerjahn et al., 2005), and react to 
homeostasis-perturbing elements by initiating an inflammatory reaction 
(Kreutzberg, 1996). In the healthy brain, they have a unique homeostatic 
molecular and functional signature (M0) (Butovsky et al., 2014, Gautier et al., 
2012, Hickman et al., 2013), which is tightly controlled by transforming growth 
factor β (TGFβ) signaling (Butovsky et al., 2014, Gosselin et al., 2014). However, 
during the course of disease, microglia lose their homeostatic molecular 
signature and functions (Butovsky et al., 2015, Holtman et al., 2015) and become 
chronically inflammatory (Perry and Holmes, 2014). Recent studies identified a 
common disease-associated microglia signature (Chiu et al., 2013, Hickman et 
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al., 2013, Holtman et al., 2015, Keren-Shaul et al., 2017, Orre et al., 2014). 
However, the mechanisms that regulate the microglial phenotype in disease have 
not been identified. In this study, we identified a role for apolipoprotein E (APOE) 
in regulating a subset of microglia, which exhibit a common disease-associated 
phenotype. This neurodegenerative phenotypic switch is triggered by TREM2, 
leading to activation of APOE signaling and subsequent suppression of 
homeostatic microglial phenotype. A functional consequence of the activation of 
TREM2-APOE pathway is that microglia lose the ability to regulate brain 
homeostasis. 
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Methods 
Mice 
C57BL/6, SOD1, Apoe–/–, mir155–/– , Cx3cr1CreERT2 mice were purchased from 
Jaxmice. Trem2–/– mice were generously provided by Dr. Marco Colonna 
(Washington Univ.). APP-PS1 mice were kindly provided by Dr. Mathias Jucker 
(University of Tübingen). These mice develop amyloid plaque deposition 
approximately at six weeks of age in the neocortex. Deposits appear in the 
hippocampus at about three to four months, and in the striatum, thalamus, and 
brainstem at four to five months(Radde et al., 2006). APP-PS1/Trem2–/–, were 
generated by crossing APP-PS1 mice with Trem2–/– mice. Generation of Apoefl/fl 
mice have been described recently (Wagner et al., 2015) and these mice were 
used for microglia specific deletion of Apoe. If not otherwise stated, mice were 6-
8 weeks of age at the beginning of the experiments. All mice were housed with 
food and water ad libitum. Mice were euthanized by CO2 inhalation. The 
Institutional Animal Care and Use Committee at Harvard Medical School 
approved all experimental procedures involving animals. 
Conditional genetic deletion of Apoe in microglia  
To induce Cre recombinase expression(Sohal et al., 2001), a single dose of 
tamoxifen (75 mg/kg of body weight) in corn oil (Sigma) was injected i.p. for 5 
consecutive days. For genetic depletion of APOE in microglia cells, Apoefl/fl were 
crossed with tamoxifen-inducible Cx3cr1CreERT2 transgenic mice. Recombination 
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was induced in Cx3cr1CreERT2/Apoefl/fl adult mice and Cx3cr1wt/w/Apoefl/fl 
littermates were used as controls.   
Immunohistochemistry 
Following immersion fixation in 4% PFA, brains were dehydrated and embedded 
in paraffin. H&E staining was performed according to standard procedures. For 
immunohistochemical staining, frontal sections (2-5 µm) were collected on 
superfrost slides, deparaffinized in xylol and rehydrated. After heat induced 
antigen retrieval, the following primary antibodies were used for detection: 
Neurons, NeuN (clone A60, Millipore, 2 µg ml–1), myelin/oligodendrocytes, 
CNPase (clone SMI91, Sternberger Monoclonals, 1.5  µg ml–1), progenitor cells, 
NG2 (polyclonal, Millipore, 0.4 µg ml–1, AB5320), 
microglia/macrophages/monocytes, Iba1 (polyclonal, #019-19741; WAKO 
Chemicals, 1 µg ml–1), resident microglia, P2RY12 (polyclonal, 0.4 µg ml–1, 
validated in ref. (Butovsky et al., 2015, Butovsky et al., 2014), APOE (polyclonal, 
AB947; Millipore, 5 µg ml–1) phosphorylated neurofilament (pNF; (clone SMI31 
Biolegend; 1:2,000), TMEM119 antibody (Sigma, HPA051870; 1:300) and 
activated caspase 3 CM1 (Indu Pharmaceuticals CM1; 1:50,000). Detection was 
performed with the respective secondary antibodies and diaminobenzidine. For 
immunofluorescence staining, antigen retrieval was performed for 30 min at 96°C 
in 10 mM citrate buffer pH 6.0. Subsequently, sections were permeabilized with 
0.2% TritonX-100 (Roche) in TBS for 5 min. Tissues were blocked in Pierce 
Protein-Free T20 blocking buffer (Thermo Scientific) and treated with 1% Sudan 
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Black to reduce autofluorescence. Sections were stained at 4°C overnight, 
washed with TBS Tween (TBS-T) and incubated with secondary donkey anti-
rabbit Alexa555 antibody (Life Technologies, 6 µg ml-1) or chicken anti-rabbit 
Alexa488, anti-mouse Alexa647 (Life Technologies, 6 µg ml-1) during 90 min. 
APOE was stained with goat anti-APOE (polyclonal, Millipore, 5 µg ml-1) and 
detected with the superclonal rabbit anti-goat Alexa555 (Thermo Scientific, 1 µg 
ml-1). Sections were washed again and slides were mounted with DAPI-
Fluoromount-G (SouthernBiotech, Birmingham, USA). Staining and analyses of 
APP-PS1/Trem2–/– and APP-PS1 tissues were performed on cryo or floating 
sections and the following additional antibodies were used: mClec7a (clone R1-
8g7, Invivogene, 1:30); Aβ (clone 6E10, Covance, 1:100 or Mob 410-05, 
Zytomed, 1:100); goat anti-mouse Alexa405; chicken anti-rat Alexa488 or 
Alexa647. Sections were permeabilized with 0.2% TritonX-100 as mentioned 
above with subsequent antibody incubations, respectively. Data acquisition and 
quantification was performed using a Leica TCS SP5 confocal microscope and 
Leica application suite software (LAS-AF-lite). Quantification of positive staining 
within microglia or amyloid-plaque region was performed using the LAS-AF 
quantification tool. Briefly, the region of interest was carefully selected and the 
sum of the values of the pixels in the selection was calculated. For quantification 
of APOE-signal in human microglia, only cells with fully visible cell bodies, away 
from plaques or astrocytes were used. Selected area was 300µm2 and 30 cells 
were measured each (n=3 AD subjects vs. n=3 controls). For quantification of 
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CLEC7a signal within single plaque associated microglia in mouse brains, we 
measured an area of 250µm2 from 10-14 plaques each (n=5 APP-PS1 versus 
n=5 APP-PS1/Trem2–/–). Reduction of P2RY12 protein amount in plaque area 
associated microglia was measured in 3,000µm2 from 15 plaques each (n=5 
APP-PS1 versus n=5 APP-PS1/Trem2–/–). For quantitative evaluation of P2ry12 
and dystrophic axons in human AD brains, double staining for P2RY12 with Aß 
or phosphorylated neurofilament was performed on paraffin sections as 
described previously(Bauer and Lassmann, 2016). After deparaffinization heat 
induced epitope retrieval was performed in EDTA buffer (pH: 8.5). The primary 
antibodies (rabbit polyclonal anti-P2RY12; mouse monoclonal anti-Amyloid ß, 
Clone W02, Millipore and mouse monoclonal anti-phosporylated neurofilament, 
SMI31; Sternberger Monoclonals, Affiniti Res Prod.) were applied together 
overnight. Antibody binding was visualized with either alkaline phosphatase-
conjugated anti-mouse antibodies or with biotinylated anti-rabbit secondary 
antibodies and peroxidase-conjugated streptavidin. Alkaline phosphatase or 
peroxidase reaction products were visualized by development with fast blue BB 
salt (blue) or amino ethyl carbazole (AEC; red), respectively.  
Human cortical specimens 
We examined the cortices (prefrontal cortex, Brodmann area 9-15) of brains 
deposited at Massachusetts Alzheimer Disease Research Center (MADRC; NIA 
P50 AG005134) at Massachusetts General Hospital.  Brain tissue from the 
selected autopsies was accompanied by the reports generated by the 
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Neuropathology Core of the MADRC. These reports include neuropathology 
diagnosis of Alzheimer Disease (AD)-associated changes and descriptive clinical 
information on the severity of neurological signs and symptoms of AD-associated 
cognitive decline. AD subjects (n=3, 2 females and 1 male) and healthy controls 
(n=3) for laser capture microdissection with high fidelity mRNAs were age- and 
race-matched. Bioanalysis was performed a priori using the Agilent (Waldbronn 
GmbH) RNA 6000 Pico chip human tissue to assess the quality of RNA 
extracted. An independent set of AD-patients (n=3, 2 females and 1 male) versus 
healthy control (n=3, 3 males) was used for fluorescence microscopy. The 
Institutional Review Board at Massachusetts General Hospital provided an 
exemption for the protocol describing research on postmortem human brain 
tissue analyzed in this study.   
RNA isolation, nanostring RNA counting, quantitative real-time 
PCR 
Total RNA was extracted using mirVanaTM miRNA isolation kit (Ambion) 
according to the manufacturer's protocol. Nanostring nCounter technology 
(http://www.nanostring.com/) allows expression analysis of multiple genes from a 
single sample (Butovsky et al., 2014). We performed nCounter multiplexed target 
profiling of 400 to 542 microglial transcripts (MG400 and MG550, see MG 
custom-chip design). 100 ng of total RNA per sample were used in all described 
nCounter analyses according to the manufacturer's suggested protocol (Butovsky 
et al., 2014). Nanostring analysis was performed on RNA from human LCM 
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samples according to manufacturer's suggested protocol for Single cell Analysis. 
A third of the RNA sample was first retro-transcribed into cDNA using 
SuperScript VILO master mix (Invitrogen). A Multiple Target Enrichment (MTE) 
was performed with 70 selected primer pairs to linearly pre-amplify human LCM 
samples using Taqman PreAmp master mix (Applied Biosystems). Resulting 
amplified material was then directly hybridized with nCounter Codeset. Total 
RNA (30 ng) and 3 ng of RNA with specific miRNA probes (Applied Biosystems) 
were used for reverse transcription reaction according to the manufacturer (high-
capacity cDNA Reverse Transcription Kit; Applied Biosystems). mRNA or 
miRNAs levels were normalized relative to GAPDH or U6, respectively. Real-time 
PCR reaction was performed using Vii7 (Applied Biosystems). All qRT-PCRs 
were performed in duplicate, and the data are presented as relative expression 
compared to GAPDH or U6 as mean ± s.e.m.  
MG550 and human MG447 chip design 
The MG550 Nanostring chip was designed using the quantitative Nanostring 
nCounter platform. Selection of genes is based on analyses that identified genes 
and proteins, which are specifically or highly expressed in adult mouse microglia 
plus 40 inflammation-related genes, which were significantly affected in EAE, 
APP-PS1 and SOD1 mice. Two other versions were done after MG400. MG468 
contains an additional 48 inflammation/phagocytosis-related genes (Butovsky et 
al., 2015). Using this signature, we generated a new version of Nanostring-based 
microglia chip termed MG550 that encompasses 400 unique and enriched 
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microglial genes we have identified previously (Butovsky et al., 2014) and 
additional 150 inflammation-, inflammasome- and phagocytosis-related genes. 
The human MG447 chip was previously described in ref (Butovsky et al., 2015). 
Induction of EAE 
Female mice (6-8 weeks) were injected s.c. in both flanks with 100 μg myelin 
oligodendrocyte glycoprotein (MOG) 35–55 peptide dissolved in PBS and 
emulsified in an equal volume CFA (Difco) supplemented with 5 mg ml–1 
Mycobacterium tuberculosis H37Ra and injected twice i.p. with 200 ng pertussis 
toxin (List Biological Laboratories) administered on the day of immunization and 
48 h later. Clinical assessment of EAE was performed daily after disease 
induction according to the following criteria: 0, no signs of disease; 1, loss of tone 
in the tail; 2, hind limb paresis; 3, hind limb paralysis; 4, tetraplegia; 5, moribund, 
during the duration of the acute phase (15 d), or only during the progressive or 
chronic phase (days 30–50).  
Heatmaps 
Selected gene expression was averaged between the replicates (n = 3 for aging, 
APPPS1, SOD1, and n = 4 for EAE) for each disease score or time-point. For 
clustering, the z-scores were calculated using the mean of samples for all 
disease conditions and then subsequently clustered using K-means. A scree plot 
was used to assess the number of clusters, which suggested that four clusters 
were a suitable number to explain most of the variability in the data. Heatmaps 
were generated using R (version 3.2.0) and heatmap.2 from the gplots package.  
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Circos plot 
The custom-made microglia transcriptional signatures (Figure IV-3I) were 
generated by retrieving genes upregulated at least 1.5-fold and p-value less than 
0.01 (Student’s T-test) in disease conditions from GSE43366, GSE60670, 
GSE62420, GSE66211, GSE66420, GSE71133, GSE55968, and GSE65067. All 
custom signatures were derived from publicly available transcriptomes 
downloaded from Gene Expression Omnibus (GEO). A GSEA algorithm was 
applied to identify the enrichment of phagocytic microglia signaling pathways in 
the microglia transcriptomes in various diseases conditions. This includes Aging, 
Mfp2-deficiency, Alzheimer’s disease, ALS, neuropathic pain, chronic pain and 
Mecp2-deficiency.  All custom signatures were derived from publically available 
rodent transcriptomes downloaded from Gene Expression Omnibus. Statistical 
significance of GSEA results was assessed using 1,000 sample permutations. A 
nominal P value less than 0.001 was used to determined pairwise transcriptome 
connectivity. A Circos graph was generated using Circos package 0.68.12. 
Transcription factor binding site analysis 
Web-based system for the detection of overrepresented conserved transcription 
factor binding sites, oPOSSUM (Ho Sui et al., 2007, Ho Sui et al., 2005, Kwon et 
al., 2012), was used to analyze promoter sequences of specific co-regulated 
gene sets. Promoter sequences (250bp) of APOE-induced and repressed gene 
sets in phagocytic conditions were analyzed. Transcription factor binding sites 
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were considered significant if either the z-score was above 10 or the Fisher score 
was above 5.  
Promoter motif analysis 
A GSEA algorithm was used to identify genes that are differentially expressed in 
microglia transcriptomes from lipid disorder (Mfp2–/–)(GSE66420), ALS (SOD1) 
(GSE43366), AD (5xFAD) (GSE65067) and aging(GSE62420), as compared with 
their control counterparts. High-scoring differentially expressed ‘leading-edge’ 
social genes were selected on the basis of their presence in the TREM2-
responsive gene signature 5xFAD/Trem2–/– and SOD1/Trem2–/– mice. The 
statistics were determined using Euclidean distance. 
Ingenuity Pathway Analysis (IPA) 
Data were analyzed using Ingenuity software (Ingenuity Systems, 
http://www.ingenuity.com). Differentially expressed genes (with corresponding 
fold changes and P values) were incorporated in canonical pathways and bio-
functions and were used to generate biological networks as described 
previously(Butovsky et al., 2014). Briefly, uploaded data set for analysis was 
filtered using the following cutoff definitions: fivefold change, P < 0.01.  
 
 93 
 
Results 
Reciprocal induction of APOE and suppression of TGFβ signaling in 
disease-associated microglia  
To investigate the underlying molecular mechanisms that regulate dysfunction of 
microglial phenotype in neurodegenerative disease, we isolated microglia and 
analyzed transcriptomes during aging and disease progression in mouse models 
of ALS (SOD1 mice), Alzheimer’s disease (AD, APP-PS1 mice) and multiple 
sclerosis (MS, EAE; experimental autoimmune encephalomyelitis). To identify 
common patterns of gene expression during aging and disease progression, we 
performed k-mean clustering and identified two major clusters (Figure IV-1A). 
Cluster 1 was associated with the loss of 68 homeostatic microglial genes, 
including P2ry12, Tmem119, Gpr34, Jun, Olfml3, Csf1r, Hexb, Mertk, Rhob, 
Cx3Cr1, Tgfbr1 and Tgfb1 and transcription factors such as Mef2a, Mafb, Jun, 
Sall1 and Egr1, which are enriched in adult microglia (Butovsky et al., 2014, 
Matcovitch-Natan et al., 2016, Buttgereit et al., 2016). Cluster 2 was associated 
with upregulation of 28 inflammatory molecules including Spp1, Itgax, Axl, Lilrb4, 
Clec7a, Ccl2, Csf1 and Apoe, which was one of the most upregulated genes 
(Figure IV-1A). We have termed this microglial neurodegenerative phenotype as 
MGnD, in contrast to M0-homeostatic adult microglia (Gautier et al., 2012, 
Hickman et al., 2013, Butovsky et al., 2014). Linear regression analysis showed 
a negative correlation of Mef2a, Sall1 and Tgfbr1 with disease progression in 
EAE, SOD1 and APP-PS1 mice (Figure IV-1B). In contrast, induction of Apoe 
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was positively correlated with disease progression (Figure IV-1B). Importantly, 
during acute and relapsing phases in EAE, microglia transcriptome profiling 
showed global suppression of the homeostatic molecules [e.g., P2ry12, 
Tmem119, Tgfbr1, Mafb, Mef2a, Sall1 and Egr1 (Butovsky et al., 2014, Gautier 
et al., 2012, Hickman et al., 2013, Matcovitch-Natan et al., 2016) and their 
restoration during the remission phase of EAE (Figure IV-1C). In contrast, Apoe 
was reciprocally upregulated (Figure IV-1C). Ingenuity pathway analysis (IPA) 
identified APOE and TGFβ as the major upstream regulators of the MGnD 
microglia (Figure IV-1D). Of note, among previously identified TGFβ-dependent 
homeostatic microglia genes (Butovsky et al., 2014), top-suppressed Olfml3, 
P2ry12, Tmem119, Mef2a, Jun, Sall1 and -upregulated Apoe and Axl were 
similarly and significantly affected during disease progression (Figure IV-1E).  
 
The MGnD-microglia subset is associated with neuritic Aβ-plaques and 
diffuse neuritic dystrophy in the AD cortex 
In AD, brain pathology is characterized by a widespread neuritic dystrophy 
presenting with filamentous inclusions and a swollen appearance associated with 
neurite degeneration (Larner, 1995). These dystrophic axons are enlarged and 
show intense reactivity for phosphorylated neurofilaments (Sternberger et al., 
1985). To address whether a microglial phenotype switch from M0-homeostatic 
to MGnD-neurodegenerative is specifically associated with neuritic dystrophy in 
AD, we analyzed brain specimens from APP-PS1 mice and human AD. We 
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found previously that P2ry12 is a microglia specific homeostatic molecule 
(Butovsky et al., 2015, Butovsky et al., 2014) and its expression is suppressed in 
MGnD microglia. In contrast, Clec7a gene expression was induced in MGnD 
microglia (Figure IV-1A). Thus, in order to distinguish M0- vs. MGnD-microglia 
we used a combination of P2ry12 and Clec7a mAbs, respectively. We found that 
Clec7a+/P2ry12– microglia were associated with Aβ-plaque in APP-PS1 mice 
(Figure IV-2A). We identified three microglial subsets based on P2ry12 and 
Clec7a expression: 1) Clec7a–/P2ry12+ microglia (not associated with Aβ-
plaques); 2) Clec7aLow/P2ry12Low microglia (in close proximity to Aβ-plaques); 
and 3) Clec7a+/P2ry12– microglia (associated with neuritic Aβ-plaques) (Figure 
IV-2A). Importantly, Clec7a+/P2ry12– microglia were associated specifically with 
phosphorylated neurofilaments (NF+) in neuritic plaques in APP-PS1 mice 
(Figure IV-2B). In order to determine whether the Clec7a+/P2ry12– microglia 
subset exhibit the MGnD molecular signature, we sorted FCRLS+/Clec7a+ vs. 
FCRLS+/Clec7a– microglia from 24-month old APP-PS1 mice. We detected 
significantly more FCRLS+/Clec7a+ microglia in APP-PS1 compared to age-
matched WT mice (data not shown). Nanostring transcriptome profiling of 
isolated microglia showed that the phenotype of Clec7a+ microglia was similar to 
MGnD microglia identified in SOD1, EAE and APP-PS1 mouse models and 
during aging (Figure IV-2C). Among suppressed key microglial homeostatic 
genes were P2ry12, Tmem119, Olfml3, Csf1r, Rhob, Cx3Cr1, Tgfbr1, Tgfb1, 
Mef2a, Mafb, Sall1 and the upregulation of inflammatory molecules including 
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Spp1, Itgax, Axl, Lilrb4, Clec7a, Csf1 and Apoe, which was among the most 
upregulated genes (Figure IV-2C and 2D). Of note, transition of microglia from 
Clec7a– to Clec7aInt to Clec7aHi was correlated with increased expression of 
Apoe and suppression of the homeostatic molecules (Figure IV-2D). RNA-seq 
analysis of three microglial subsets validated the results of Nanostring analysis 
and showed that only FCRLS+/Clec7a+ microglia acquired an MGnD signature 
(Figure IV-2E−F). 
To investigate whether a microglial phenotype switch is specifically 
associated with neuritic plaques, we performed immunohistochemical analysis of 
human AD brains by double staining for P2RY12 with antibodies to amyloid -
peptide (Aβ) or phosphorylated neurofilaments (pNF). P2RY12+ homeostatic 
microglia were preserved in Aβ-diffuse plaques which are not associated with 
neuritic pathology and P2ry12 signal was lost in pNF+ neuritic plaques in human 
AD brains (Figure IV-2G). Loss of P2RY12+ microglia was significantly correlated 
with axonal dystrophy in AD brains, but not with the extent of Aβ deposition 
(Figure IV-2H). We confirmed by immunohistochemical analysis increased APOE 
expression in microglia in close proximity to Aβ-plaque in AD brains (data not 
shown).   
 
Phagocytosis of apoptotic neurons suppresses homeostatic microglia 
A common feature in neurodegeneration is the occurrence of synaptic, dendritic 
or axonal apoptosis and neuritic dystrophy (Mattson et al., 1998, Ofengeim et al., 
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2015, Larner, 1995). To determine the mechanisms by which the MGnD-
microglia are induced in neurodegeneration, we performed stereotaxic injections 
of fluorescently-labeled apoptotic neurons into the cortex and hippocampus of 
naïve mice. Apoptotic neurons induced the recruitment of P2ry12+ microglia 
towards the site of injection 16 h post-injection (Figure IV-3A). P2ry12+ microglia 
changed their morphology from an M0-homeostatic non-phagocytic (MG-nΦ 
phenotype to an amoeboid-phagocytic (MG-dNΦ phenotype at the vicinity of the 
site of injection (Figure IV-3A−C). Of note, induction of MGnD microglia was not 
detected in PBS injected brains. Apoptotic neurons and neuronal fractions were 
internalized by P2ry12+ microglia (Figure IV-3B). Induction of APOE was 
detected in MG-dNΦ microglia (Figure IV-3C). Increased expression of Apoe was 
detected as early as 3h post-injection and reached a peak by 16 h post-injection. 
Restoration of homeostatic P2ry12+/Clec7a- microglia were observed at 14 days 
post-injection (data not shown). Transcriptome profiling of sorted MG-dNΦ and 
MG-nΦ microglia (Figure IV-3D and 3E) showed that phagocytosis of apoptotic 
neurons induced a microglial molecular phenotype similar to MGnD disease-
associated microglial phenotype. Unique microglial homeostatic genes including 
Tmem119, Egr1, Hexb, Gpr34, P2ry12, Olfml3 and Tgfbr1 were suppressed in 
phagocytic microglia, whereas Apoe was the major upregulated gene among 
other inflammatory molecules (Figure IV-3F). This was confirmed by qPCR 
analysis of key microglial genes including upregulation of Apoe and miR-155, a 
regulator of inflammation in microglia (Butovsky et al., 2015) and suppression of 
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Tgfbr1 (TGFβ signaling), which is critical to maintain homeostatic microglia 
(Butovsky et al., 2014, Gosselin et al., 2014).  
 To confirm the phenotypic switch on the protein level, we performed 
quantitative mass spectrometry analysis of phagocytic vs. non-phagocytic 
microglia 16 h post-injection. Apoe and Lgals3 were highly expressed in 
phagocytic microglia. In contrast, both Rgs10 and Bin1, two homeostatic 
microglial proteins (Butovsky et al., 2014), were suppressed (Figure IV-3H). To 
determine whether the MG-dNΦ microglia is closely related to disease models, 
we used gene set enrichment analysis (GSEA) (Subramanian et al., 2005). 
GSEA assesses whether the expression of a previously defined group of related 
genes is enriched in one biological state. The disease models included 
previously identified microglia transcriptomes from mouse models of neuropathic 
pain (GSE60670), chronic pain (GSE71133), Rett syndrome (Mecp2–/–) 
(GSE66211), lipid disorder (Mfp2–/–) (GSE66420), ALS (SOD1) (GSE43366), AD 
(5xFAD) (GSE65067), brain irradiation (GSE55968), and aging (GSE62420). 
Circos plot network analysis presented an overlap of the phagocytic microglial 
phenotype with the microglia molecular signature during aging and in a model of 
brain irradiation. Most importantly, the MG-dNΦ microglia signature was 
significantly enriched in microglia transcriptomes from mouse models of 
Alzheimer’s disease (5XFAD), ALS (SOD1) and MFP2 deficiency, which is 
associated with cerebellar degeneration (Verheijden et al., 2013). In contrast, 
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microglial changes associated with neuropathic and chronic pain models or in 
MECP2 deficiency were not connected (Figure IV-3I).  
 
APOE regulates transcriptional and post-transcriptional programs of the 
MGnD phenotype and function  
We previously reported that Apoe expression is downregulated in microglia 
during development, which correlates with the induction of M0-homeostatic 
microglial genes (Butovsky et al., 2014). Moreover, Apoe expression is markedly 
increased in microglia progenitors from CNS Tgfb1−/− mice (Butovsky et al., 
2014). To assess the role of Apoe in the induction of MGnD microglia, when 
phagocyting apoptotic neurons, we performed RNA-Seq analysis on Apoe–/– vs. 
WT transcriptomes from MG-nΦ vs MG-dNΦ microglia. We defined clusters 
based on differentially expressed genes between WT non-phagocytic vs. 
phagocytic vs. Apoe–/– phagocytic microglia (Figure IV-4A). We defined clusters 
based on differentially expressed genes between WT non-phagocytic vs. 
phagocytic vs. Apoe–/– phagocytic microglia (Figure IV-4A). Clusters 1-3 show 
446 genes induced in phagocytic microglia which were repressed in Apoe–/– 
microglia. Of note, 15 genes among commonly upregulated in disease were 
suppressed by APOE (Figure IV-4A). Figure IV-4B shows selected APOE-
repressed genes. Clusters 4-7 show 483 suppressed genes in phagocytic 
microglia which were restored in Apoe–/– phagocytic microglia. Of note, among 68 
genes commonly suppressed in disease, 19 genes were restored in Apoe–/– 
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phagocytic microglia including P2ry12, Tgfbr1 and Mef2a (Figure IV-4A). To 
assess an intrinsic role of APOE regulation in cell-specific manner, we 
specifically deleted Apoe in microglia from Cx3cr1Cre/+/Apoefl/fl mice. qPCR 
analysis confirmed Apoe deletion in Cx3cr1Cre/+/Apoefl/fl  microglia as compared 
to Cx3cr1wt/wt/Apoefl/fl microglia. Moreover, gene expression of Clec7a was 
repressed and Csf1r, Tgfb1, Tgfbr1 was restored in Cx3cr1Cre/+/Apoefl/fl microglia 
(Figure IV-4C). Conditional deletion of Apoe in phagocytic microglia showed 
similar pattern of expression of selected genes as was observed in phagocytic 
microglia from global Apoe–/– mice (Figure IV-4A).  
 We found that transcription factors Cited2, Mef2a and Smad3 which are 
essential in TGFβ signaling (Quinn et al., 2001, Chou and Yang, 2006) were 
repressed in Apoe–/– phagocytic microglia (Figure IV-4D). Moreover, Spi1 (PU.1) 
a lineage-determining transcription factor for myeloid cells was suppressed by 
APOE (Figure IV-4A). On the opposite, APOE induced Tfec and specifically 
Bhlhe40, which is essential for pathogenicity in neuroinflammation (Lin et al., 
2014, Sun et al., 2001) (Figure IV-4D). To investigate the mechanisms of APOE 
regulation in microglia, we performed a Transcription Factor Binding Site (TFBS) 
analysis in genes that were differentially regulated in phagocytic Apoe–/– 
microglia. Transcription factor binding site over-representation analysis using 
oPOSSUM, showing that the promoter regions (250bp upstream of TSS) of 28 
APOE-induced and 39 APOE-repressed genes are enriched for predicted binding 
sites (Figure IV-4E). MEF2A and SPI-B (Spi-1/PU.1 related binding motifs) were 
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significantly enriched in genes repressed by APOE, implying a major role of 
these transcription factors in the APOE-dependent gene regulation (Figure 
IV-4E). Figure IV-4F shows major APOE–induced and –repressed transcription 
factors and their direct targets. Gene-regulatory network orchestrates two distinct 
pathways in phagocytic microglia. Both regulators function in concerted ways to 
activate appropriate genes. 
These results show that APOE signaling has dual actions on microglia 
regulation in neurodegeneration: 1) suppression of microglia transcriptional 
homeostatic program including Mef2a, Mafb, Smad3, PU.1 and 2) induction of 
inflammatory program including transcription factor Bhlhe40 and Tfec. 
 
Genetic targeting of Trem2 suppresses APOE pathway and restores the 
homeostatic microglia in APP-PS1 and SOD1 mice 
Recently, Wang et al. showed that TREM2 is a sensor of membrane-associated 
lipids including phosphatidylserine (PS) focally exposed on apoptotic cells and 
processes or synapses of damaged neurons (Wang et al., 2015). We found that 
blocking phosphatidylserine on apoptotic neurons with Annexin V protein, which 
specifically binds and blocks phosphatidylserine (Koopman et al., 1994), reduced 
microglial phagocytosis by 88% (Figure IV-5A). As shown in Figure IV-3, 
apoptotic neurons suppress homeostatic genes in microglia. Thus, we asked 
whether apoptotic neurons activate APOE pathway via TREM2 on microglia by 
comparing Trem2–/– and WT mice. We found that the expression of homeostatic 
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genes including P2ry12, Gpr34, Tmem119, Tgfbr1 and Csf1r were restored in 
Trem2–/– phagocytic microglia as compared to WT phagocytic microglia (Figure 
IV-5B), whereas Apoe and miR-155 were suppressed in Trem2–/– phagocytic 
microglia (Figure IV-5C). To confirm whether TREM2 induces MGnD in disease, 
we genetically ablated Trem2 in APP/PS1 and SOD1 mice. Nanostring 
transcriptome profiling of brain microglia isolated from APP-PS1/Trem2–/– mice 
showed suppression of 6 inflammatory molecules including Axl, Clec7a, Csf1, 
Itgax, Cd34 and Apoe, which were among the most upregulated genes in 
common disease-associated signature (Figure IV-5D). Among 108 restored 
genes in APP-PS1/Trem2–/– mice, 54 were commonly suppressed homeostatic 
microglial genes in disease including P2ry12, Tmem119, Gpr34, Olfml3, Csf1r, 
Mertk, Rhob, Cx3Cr1, Tgfbr1 and Tgfb1 and transcriptional factors such as 
Mef2a, Mafb and Sall1 (Figure IV-5D). Moreover, we confirmed by protein level 
restoration of P2ry12 and suppression of Clec7a in microglia associated with Aβ-
plaque in APP-PS1/Trem2–/– mice as compared to APP-PS1 mice (Figure 
IV-5E−G). In SOD1/Trem2–/– microglia, among 36 downregulated inflammatory 
genes, 11 genes were common to disease-associated signature. Among 240 
restored genes in SOD1/Trem2–/– mice, 66 were commonly suppressed 
homeostatic microglial genes in disease (Figure IV-5H). Of note, P2ry12 and 
Fabp5 gene targets of Mef2a and Bhlhe40 transcription factors, shown in Figure 
IV-4F, were restored and downregulated respectively, by Trem2 genetic ablation 
in disease. Importantly, transcription factors including Mef2a, Mafb and Sall1 and 
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TGFβ signaling (Tgfb and Tgfbr1), which were restored in Trem2–/– microglia in 
disease, were similarly restored in Apoe–/– phagocytic microglia. 
Immunohistological analysis of P2ry12 and Clec7a expression in spinal cords 
from SOD1/Trem2+/– at 115d of age showed appearance of Clec7a+/P2ry12– 
microglia. At this stage, Clec7a+/P2ry12– microglia were not detected in 
SOD1/Trem2–/– (Figure IV-5I). Importantly, Clec7a–/P2ry12+ homeostatic 
microglia were preserved in SOD1/Trem2–/– mice (Figure IV-5I). Statistical 
analysis showed restoration of P2ry12 and suppression of Clec7a in microglia 
from SOD1/Trem2–/– mice as compared to SOD1/Trem2+/– mice (Figure IV-5J 
and 5K). To validate the role of TREM2 in regulation of the microglial phenotype 
switch in disease, we analyzed publicly available rodent microglia transcriptomes 
under degenerative conditions, which includes: 5XFAD, SOD1, Mfp2–/– and aged 
22-month old mice. Using GSEA, our analysis showed that rodent microglia 
under neurodegenerative/aging conditions were enriched in TREM2 
transcriptional signature (Figure IV-6A−D). Among all four-disease models, 
TREM2-induced common genes including Clec7a, Gpnmb, Fabp5, Lgals3, Csf1 
and Ch25h which were also induced by APOE. 
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Figure IV-1 Reciprocal induction of APOE and suppression of TGFβ signaling in disease-
associated microglia 
(A) K-means clustering of 95 significantly affected common genes in FCRLS+ microglia during 
aging and disease progression as determined by Nanostring MG550 microglial chip analysis. 
Vertical lanes represent mean of biological replicates per disease stage/condition in WT (n = 12), 
EAE (n = 18), SOD1 (n = 11) and APP-PS1 (n = 12) mice. Cluster 1 represents upregulated genes 
and clusters 2-4 represents suppressed homeostatic genes. (B) Linear regression curve of Mef2a, 
Sall1, Tgfbr1 and Apoe expressions in spinal cord microglia from EAE and SOD1 mice with 
different disease scores and brain microglia during disease course in APP-PS1. Thick line 
indicates 95% confidence interval of the regression line. (C) Nanostring transcriptome analysis of 
selected homeostatic and disease-associated microglial genes during disease stages in EAE. Data 
are presented as mean ± s.e.m. *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA 
followed by Dunnett´s multiple-comparison post-hoc test. (D) Ingenuity pathway analysis (IPA) 
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shows common nodes significantly affected in microglia in all three-mouse models in disease. 
For each molecule in the data set, the expression fold change compared to normal, healthy 
microglia is presented. The legend shows prediction state and relationships. Solid lines represent 
a direct and dotted lines an indirect interaction between the two genes. (E) Heatmap (Pearson 
correlation; average linkage) of significantly affected genes dysregulated in all three diseases as 
determined by Nanostring microglial chip analysis.  
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Figure IV-2 MGnD-microglia are associated with neuritic Aβ-plaques. 
(A) Representative immunohistochemical staining for P2ry12+ and Clec7a+ in microglia at the 
vicinity of Aβ-plaque in APP-PS1 mice (24 months). MGnD microglia around the plaque (red 
arrows). MGnD transitioning to the plaque (yellow arrows). M0-homeostatic microglia (white 
arrows). Scale bar, 20 μm. (B) Representative immunohistochemical staining for P2ry12+ and 
Clec7a+ in microglia associated with neuritic plaque (phosphorylated neurofilament; pNF) in 
APP-PS1 mice (24 months). Scale bar, 20 μm. (C) Heatmap of significantly affected genes in 
Clec7a+ vs. Clec7aint vs. Clec7a– FCRLS+ microglia in APP-PS1 vs. WT mice (n = 5 per group; 
24 months). Selected homeostatic and inflammatory genes are highlighted in blue and red, 
respectively. (D) Selected genes shown in (C). Dot plots show mRNAs transcripts (mean ± 
s.e.m). *p < 0.05, **p < 0.01, ***p < 0.001, ****p< 0.0001 by one-way ANOVA followed by 
Tukey´s multiple-comparison post-hoc test. (E) Heatmap of selected significantly affected genes 
in Clec7a+ vs. Clec7a– FCRLS+ microglia in APP-PS1 vs. WT mice (n = 5 per group; 9 months). 
Selected homeostatic and inflammatory genes are highlighted in blue and red, respectively. (F) 
Selected genes shown in (E). Dot plots show FPKM (mean ± s.e.m). *p < 0.05, **p < 0.01, ***p 
< 0.001, ****p< 0.0001 by one-way ANOVA followed by Tukey´s multiple-comparison post-
hoc test. (G) Representative immunohistochemical staining for P2ry12 (red) with Aß (left figures) 
or phosphorylated neurofilament (pNF) in diffuse vs. neuritic plaques in human AD brain. Scale 
bar, 100 μm. (H) Linear regression curve of P2ry12+ microglia with dystrophic axons in the 
temporal cortex of control and AD patients defined by CERAD criteria and Braak stages (n = 14) 
and age matched controls (n = 10). 
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Figure IV-3 Phagocytosis of apoptotic neurons suppresses homeostatic microglia. 
(A) Representative immunohistochemical staining for P2ry12+ microglia in the site of injection of 
apoptotic neurons (n = 6) in C57BL/6 WT mice. MG-dNΦand MG-nΦ represent phagocytic 
and non-phagocytic microglia respectively. Scale bar, 80 μm. (B) Orthogonal projections of 
confocal z-stacks show intracellular apoptotic neurons (labeled before injection with Alexa488; 
green) in P2ry12+ microglia (n = 6), 16 h post-injection. Scale bar, 5 μm. Data show one of two 
individual experiments. (C) Representative immunohistochemical staining for Apoe in P2ry12+ 
phagocytic microglia. White arrows point to non-phagocytic Apoe– microglia; yellow arrows 
point to Apoe+ phagocytic microglia (n = 3). Scale bar, 15 µm. (D) Phagocytic CD11b+/FCRLS+ 
microglia containing Alexa488+ apoptotic neurons and non-phagocytic microglia from the same 
injection site 16 h later. (E) Heatmap of significantly affected genes in phagocytic (n = 4) vs. non-
phagocytic (n = 4) microglia 16 h post-injection with apoptotic neurons. Selected homeostatic 
and inflammatory genes are highlighted in blue and red, respectively. Data show one of two 
individual experiments. (F) Top-20 significantly affected genes shown in (E). Bars show mRNA 
transcript numbers (ncounts) (mean ± s.e.m) detected in 100 ug total RNA. *p < 0.05 by Student t 
test, 2-tailed. (G) qPCR validation of selected genes. Gene expression level was normalized 
against Gapdh using ΔCt (n = 3-4 per group). Data are presented as mean normalized expression 
± s.e.m. *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA followed by Tukey's multiple-
comparison post hoc test. (H) Volcano plot of 552 TMT-mass spectrometry-identified proteins 
highlighting significant changes in phagocytic vs. non-phagocytic microglia. p < 0.05 by Student 
t test, 2-tailed. (I) Circos plot showing the connectivity map derived from the pairwise 
comparison of transcriptome data sets. The representations of MG-dNΦ phagocytic microglia 
RNAseq data set connectivity with RNAseq transcriptome datasets of microglia from mouse 
models of AD, ALS and MFP2 deficiency, aging and irradiation is shown in orange. Each line 
represents a pairwise data set overlap, which was determined using GSEA analysis and filtered by 
p < 0.001. 
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Figure IV-4 APOE regulates transcriptional and post-transcriptional program of MGnD 
phenotype. 
(A) K-means clustering (k = 4) of 1,249 significantly affected genes in bulk microglia (1,000 
cells per animal) from WT and Apoe–/– mice. Each vertical lane represents mean of biological 
replicates per condition in WT non-phagocytic (n = 6), WT phagocytic (n = 5) and Apoe–/– 
phagocytic (n = 4) mice. Microglia were isolated 16 h post-injection of apoptotic neurons. (B) 
Selected APOE-induced genes from WT and Apoe–/– mice 16 h post-injection of apoptotic 
neurons.  Data are presented as mean ± s.e.m. *p < 0.05, **p < 0.01, ***p < 0.001 by one-way 
ANOVA followed by Tukey´s multiple-comparison post-hoc test. (C) qPCR validation of 
selected genes in phagocytic (MG-dNΦ) microglia from Cx3cr1CreERT2/Apoefl/fl vs. 
Cx3cr1wt/Apoefl/fl controls. Gene expression level was normalized against Gapdh using ΔCt (n = 
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6-10 per group). Data are presented as mean normalized expression ± s.e.m. *p < 0.05, **p < 
0.01, by Student t test, 2-tailed. (D) Selected APOE-repressed and induced Transcription Factors 
(TFs) from WT and Apoe–/– mice 16 h post-injection of apoptotic neurons. Data are presented as 
mean ± s.e.m. *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA followed by Tukey´s 
multiple-comparison post-hoc test. (E) Transcription factor binding site (TFBS) over-
representation analysis using oPOSSUM, showing that the promoter regions (250bp upstream of 
TSS) of 28 APOE-induced and 39 APOE-repressed genes are enriched for predicted binding 
sites. (F) Target analysis shows gene-regulatory networks orchestrates two distinct pathways in 
phagocytic microglia. Both regulators function in concerted ways to activate appropriate genes. 
Red lines, gene activation inputs; Blue lines, gene repression inputs. 
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Figure IV-5 Genetic targeting of Trem2 suppresses APOE pathway and restores the 
homeostatic microglia in APP-PS1 and SOD1 mice. 
(A) Quantification of phagocytosis efficiency of apoptotic vs. Annexin V-pretreated apoptotic 
neurons (n = 5 per group). Bars show relative fold change (mean ± s.e.m) (****p < 0.001 by 
Student t test, 2-tailed). (B) qPCR analysis of selected homeostatic genes in phagocytic (MG-
dNΦ microglia from Trem2–/– vs. WT mice (n = 4 per group). Data are presented as mean ± 
s.e.m. *p < 0.05, **p < 0.01 by one way ANOVA. (C) qPCR analysis of Apoe and miR-155 
expression in phagocytic (MG-dNΦ) microglia from Trem2–/– vs. WT mice (n = 3-4 per group). 
Data are presented as mean ± s.e.m normalized against Gapdh and U6 expression using ΔCt. *p < 
0.05, by Student t test, 2-tailed. (D) Volcano plot based on significant differentially expressed 
genes in microglia from APP-PS1 (n = 4) vs. APP-PS1:Trem2–/– (n = 5) mice at 120 days. p < 
0.05 by Student t test, 2-tailed. Selected restored homeostatic and suppressed inflammatory genes 
are highlighted in red and blue, respectively. (E) Representative immunohistochemical staining 
for P2ry12, Clec7a and Aβ in APP-PS1 vs. APP-PS1:Trem2–/– mice (120 days). Scale bar, 20 μm. 
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(F and G) Quantification of P2ry12 and Clec7a intensity per Amyloidβ plaque in APP-PS1 vs. 
APP-PS1:Trem2–/– mice (120 days).***p < 0.001, by Student t test, 2-tailed. (I) Volcano plot 
based on significant differentially expressed genes in microglia from SOD1:Trem2+/– (n = 9) vs. 
SOD1:Trem2–/– (n = 13) mice at 115 days (neurological score 1). *p < 0.05 by Student t test, 2-
tailed. Selected restored homeostatic and suppressed inflammatory genes are highlighted in red 
and blue, respectively. (J) Representative immunohistochemical staining for P2ry12, Clec7a and 
NeuN in SOD1:Trem2+/– vs. SOD1:Trem2–/– mice (lumbar section, 115 days). Red arrows point 
to MGnD microglia at the epicenter of the ventral horn. Yellow arrows point to MGnD 
transitioning to the ventral horn. White arrows point to M0-homeostatic microglia. Scale bar, 50 
μm. (K and L) Quantification of P2ry12 and Clec7a intensity in ventral horn of spinal cord from 
SOD1:Trem2+/– (n = 5) vs. SOD1:Trem2–/– (n = 5) mice (lumbar section, 115 days). **p < 0.001, 
***p < 0.001 by Student t test, 2-tailed.  
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Figure IV-6 Over-representation of TREM2 transcriptional signature genes in aging and 
disease. 
(A-D), GSEA plots demonstrate the over-representation of TREM2 signature in microglia 
transcriptomes of (A) MFP–/–mice; (B) aged mice; (C) SOD1 mice; and (D) 5xFAD mice 
compared with WT microglia. Genes are ranked into an ordered list according to their differential 
expression. The middle part of the plot is a bar code demonstrating the distribution of genes in the 
TREM2 transcriptional signature gene set against the ranked list of genes. The list on the right 
shows the top genes in the leading-edge subset. 
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CHAPTER V GSEA-DRIVEN META-ANALYSIS TO UNEARTH 
IMMUNE-GENE-REGULATORY NETWORKS IN THE 
MODULATION OF BRAIN FUNCTION 
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Introduction 
The immune system has been recently recognized as a key player in supporting 
CNS functions. Immune system dysfunction is associated with many neurological 
disorders, ranging from neurodevelopmental disorders to neurodegenerative 
diseases.  Immune responses and development are tightly controlled by 
signaling and transcriptional pathways and associated gene regulatory networks. 
Gene regulatory networks consist of transcriptional factors (TFs), chromatin 
modifiers, miRNAs, and long noncoding RNAs (Singh et al., 2014).  Herein, we 
focused on TFs and their coordinately activated and repressed gene expression 
in immune cells to study gene regulatory network-mediated cellular and 
molecular responses. The objective of this work is a) to delineate the immune 
gene regulatory networks and pathways underlying the regulation of brain 
behavior, and 2) to explore the activation and perturbation of these pathways in 
neurological disorders. In this chapter, I will illustrate how we implemented gene 
set enrichment analysis (GSEA), a pathway analysis tool to analyze gene 
expression data, to identify 1) immune signaling pathways disturbed in Rett-like 
mouse macrophages, 2) T-cell mediated cytokine pathways in the regulation of 
social behavior, and 3) gene-regulatory networks governing microglia phenotype 
switching in neurodegenerative diseases.   
GSEA was first developed (Subramanian et al. 2005; Tian et al. 2005; 
Mootha et al. 2003) as an alternative approach to the over-representation 
approach (ORA) using Gene Ontology (GO) categories to identify biological 
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pathways and functional processes in gene expression datasets. ORA focuses 
on lists of differentially expressed genes and uses a statistical analysis to identify 
whether any GO categories are over-represented in the input list. GSEA, on the 
other hand, represents a different approach that takes into account all the genes 
in an experiment and performs a functional class scoring (FCS), thereby allowing 
for adjustments for gene correlations (Draghici et al., 2007, Pavlidis et al., 2004). 
GSEA is a more complex and robust analysis as it not only includes the 
differential expression of genes but it also considers the ranking of the gene 
expression correlating with the phenotype, thus it preserves the pattern in gene 
expression data. 
Three key outputs are generated by GSEA for interpreting gene 
expression data: enrichment score (ES), nominal P value (Nom-P), and false 
discovery rate (FDR). First, ES reflects the degree to which a given gene set is 
over-represented at the top or bottom of all ranked genes. It is computed by 
comparing the distribution of gene ranks from the given gene set against the 
distribution for the rest of the genes using a one-sided Kolmogorov-Smirnov 
statistic (Tian et al., 2005). From the GSEA plot, the ES is the magnitude of 
maximum deviation from zero. Second, the Nom-P value is the statistical 
significance of the ES is. To calculate the Nom-P, GSEA adopts an empirical 
phenotype-based permutation test procedure to regenerate an ES with the 
permutated data (Subramanian et al., 2005). This not only allows the software to 
generate a null distribution of ES, but also it preserves the complex correlation 
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structure of the gene expression data. The Nom-P value of the observed ES is 
computed for the top-ranking gene set by comparison with the null distribution of 
the ES from each permutation (Tian et al., 2005). Last, FDR is estimated after 
adjustment for multiple hypothesis testing. In this step, multiple hypothesis 
testing first yields the normalized enrichment score (NES), which is perhaps 
more valuable in interpreting GSEA results to predict a particular pathway 
enrichment than ES, as it normalizes the ES for each gene set to account for the 
size of the set. The FDR is then computed by comparing the tails of the observed 
and null distribution of NES. Hence, it is defined as the estimated probability of a 
given NES to be a false positive (Subramanian et al., 2005). 
 GSEA queries gene expression data by using a collection of gene sets in 
the Molecular Signature Database (MSigDB). The original MSigDB was originally 
built in 2005 and had a collection of 1,325 gene sets that have been under 
constant changing and expansion. Currently, MSigDB has a catalogue of 17,779 
gene sets and consists of 8 major collections, with much broader applicability 
covering gene sets from chromosome location to upstream cis motifs, and can be 
applied to other data sets such as genotyping information and metabolite profiles.  
 The real power of GSEA lies in its flexibility. Despite the large resources 
that GSEA employs, researchers can also use GSEA’s powerful and sensitive 
algorithm for their own manually curated gene sets, allowing them to test the 
impact of gene expression changes in specific pathways. This GSEA features 
can be particularly helpful in the following scenarios: 1) If the gene expression 
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data are of good quality, i.e. the noise from the sequencing technology is low and 
the experiment design is well thought, one can expect to see only small 
variations within technical replicates and perhaps a substantial long list of 
differential expressed genes in the biological condition under study. GSEA 
results from such transcriptome can then yield tens or hundreds of pathways that 
fall below the cut offs of statistical significance due to the large database the 
software employs. Interpretation and identification of the relevant, important 
biological pathways to the underlying biological phenomena can be daunting and 
ad hoc; 2) if the transcriptome outcome is poor, with a short list of differentially 
expressed genes meeting the statistically significant cutoff, the GSEA test may 
have only a few non-relevant pathways barely meeting the statistical significance. 
Under either of the above situations, one can curate different functional gene 
sets from publicly available databases such as the ArrayExpress and Gene 
Expression Omnibus (GEO). Curating the gene sets not only allows you to 
eliminate the noise that masks the moderate effect that is relevant to the 
biological condition of study, but also confirms the finding by curating multiple 
gene sets derived from independent studies.  
 We employed the GSEA method to analyze in-house and publicly 
available transcriptomes for three neuroimmunology projects. In each project, we 
used the GSEA results to generate relevant experimental testable hypotheses, 
along with other bioinformatics tools to analyze regulatory regions of TFs. By 
doing so, we were able to provide key insights into the transcriptional regulation 
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and gene regulatory network underlying immune cell phenotypic changes in 
response to different brain stimuli.  
 
Project 1: Dysfunctional microglia and macrophages in MeCP2-null mice  
Mutations in methyl-CPG-binding protein 2 (MECP2) lead to over 95% of 
classical Rett syndrome, a neurodevelopment disorder with both neurological 
and somatic impairments (Guy et al., 2001). Studies over the past decade on 
genetic mouse models of Rett syndrome have expanded our knowledge on the 
genetics and etiology of the disease and provided valuable insights on the 
underlying mechanism of the pathogenesis observed in Rett patients (Amir et al., 
1999, Cronk et al., 2015, Dunn and MacLeod, 2001, Lioy et al., 2011, Yasui et 
al., 2013, Derecki et al., 2012). 
Deletion of MeCP2 gene in mice leads to a breadth of symptoms that 
recapitulate symptoms in Rett patients (Guy et al., 2001). Studies of MeCP2 null 
mice have revealed that the immune system plays an important role in the 
pathogenesis of the symptoms (Derecki et al., 2012, Jiang et al., 2014, Li et al., 
2014a). Of note, engraftment of wild-type microglia into MeCP2-null mice via 
bone-marrow transplantation was shown to arrest disease progress and 
pathology (Derecki et al., 2012). This has prompted us to examine microglia and 
its development-related peripheral monocytes and macrophages population in 
great detail. Using flow cytometry, we found that three macrophages populations, 
microglia, meningeal macrophages and intestinal macrophages, were reduced in 
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Mecp2-null mice.  In order to define the functional role of MeCP2 and uncover 
the mechanism of macrophages loss Mecp2-null mice, we performed RNA-seq 
profiling on microglia and peritoneal macrophage derived from wild-type and 
Mecp2-null mice. Using GSEA, we first tested the enrichment of biological 
pathways in Mecp2-null microglia and peritoneal macrophages using MSigDB C2, 
which contains curated gene sets (~4738) from various sources such as literature 
and online pathway databases. We performed the analysis with phenotype 
permutation (N=1000) and this yielded more than 50 informative sets that met the 
statistical cutoffs, namely Nom-P< 0.001. Glucocorticoid signaling was ranked 
top among the list of significantly overrepresented pathways (Nom-P<0.001) in 
both Mecp2-null microglia and peritoneal macrophages. The glucocorticoid 
signaling pathway was particularly interesting to us as Fkbp5, which is a 
canonical target of glucocorticoid pathway, was highly upregulated in 
transcriptomes of Mecp2-null microglia and peritoneal macrophages. Of note, a 
previous study (Braun et al., 2012) showed that blocking glucocorticoid signaling 
using a pharmacological drug-RU486 could ameliorate symptoms and increase 
life spans of the otherwise Mecp2-null mice. Collectively, these results led us to 
hypothesize that MeCP2 represses the glucocorticoid signaling pathway and that 
over-production of glucocorticoid contributes to pathologies of Mecp2-null mice. 
We validated the functional role of Mecp2 in the regulation of glucocorticoid 
signaling using in vitro experiments. Our chromatin immunoprecipitation (ChIP) 
experiments confirmed that MeCP2 is bound to the promoters of Fkbp5 gene, 
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suggesting MeCP2 directly controls glucocorticoid signaling pathway.  In the 
absence of MeCP2, there was increased acetylation of histone H4 level, which 
corresponded to increased Fkbp5 transcription in Mecp2-null microglia and 
peritoneal macrophages transcriptome. To further investigate the role of MeCP2 
in the regulation of glucocorticoid pathway, we performed glucocorticoid signaling 
stimulation in vitro using glucocorticoid receptor agonist- dexamethasone. We 
found that there was increased transcription of fkbp5 gene in Mecp2-null bone 
marrow derived macrophages (BMDMs) as compared with wild-type counterparts 
under low doses of dexamethasone stimuli, and the difference in fkbp5 
transcription between wild-type and Mecp2-null BMDMs disappeared as 
dexamethasone doses increased. This result suggests that MeCP2 controls the 
sensitivity of glucocorticoid signaling pathway.  
 Secondly, we noticed that a subset of the glucocorticoid pathway 
signature that was up-regulated in Mecp2-null microglia and macrophages 
transcriptome, contains a subset of hypoxia-inducible genes. Correspondingly, 
GSEA results from the MSigDB C2 database also demonstrated a moderate 
correlation of hypoxia-induced genes with Mecp2-null microglia induced 
transcripts, though the NES and Nom-P value corresponding to hypoxia pathway 
were not as significant as the values corresponding to glucocorticoid pathway. To 
confirm the hypoxia pathway prediction from the GSEA results using MSigDB C2, 
we curated our own hypoxia gene sets from the GEO database, where we found 
most of the publicly available gene expression datasets (RNA_seq and 
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microarrays). When curating gene sets for a biological pathway, GSEA requires 
the input length of the gene sets to be greater than 15 and less than 500 in order 
for the program to run. To accommodate the maximum number of transcriptomes 
we downloaded from the GEO database, we derived hypoxia-induced gene 
signatures by selecting differentially expressed genes that are upregulated under 
hypoxia conditions at least 2-fold by average function. We curated 32 
independent gene sets for hypoxia pathways and found that 25 out of 32 curated 
hypoxia gene sets were significantly enriched in Mecp2-null microglia. We then 
validated this hypothesis in vitro using BMDMs under normoxia and hypoxia 
conditions.  
 A third pathway revealed by our GSEA result was the Tnf-mediated 
inflammatory pathway: there were multiple statistical significant Tnf 
transcriptional signatures overrepresented in transcriptomes of Mecp2-null 
microglia and macrophages using MSigDB C2. Moreover, transcriptome profiles 
of Mecp2-null microglia and macrophages demonstrated increased expression of 
a subset of inflammatory genes such as Tnf, IL6, Cxcl2 etc. Thus, we 
hypothesized that MeCP2 restrains inflammatory response and MeCP2 
deficiency leads to dysregulation of Tnf-mediated inflammatory responses. We 
validated this hypothesis in vitro using Tnf-stimulation in BMDMs, and in vivo 
using Tnf (intraperitoneal injection) challenge. It is worth mentioning that one of 
the Tnf pathway target, csf3, was overexpressed in Mecp2-null macrophages 
both in vitro and in vivo. Since csf3 encodes the protein granulocyte-colony 
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stimulating (GCSF), which is well-known for its function in stimulating neutrophil 
production, this led us to examine the GCSF levels in the serum and neutrophil 
population in the blood of wild-type and Mecp2-null mice. We found that the 
serum GCSF levels were increased in Mecp2-null mice without any manipulation 
in comparison with wild-type mice. Using flow cytometry method, we found 
neutrophil population was significantly increased (~5 fold) in Mecp2-null mice 
compared with wild-type mice. To determine whether severe neutrophilia 
contributes to pathologies in Mecp2-null mice, we treated wild-type and Mecp2-
null mice with antibodies against GCSF. We found that neutralizing GCSF could 
moderately increase the life span of Mecp2-null mice, suggesting that Mecp2-
mediated inflammatory pathway contributes to pathologies in Mecp2-null mice.   
 Taken all together, we have demonstrated that MeCP2 is required for 
macrophage responses to three stimuli (glucocorticoid, hypoxia and Tnf-
mediated inflammatory responses). We have provided evidence for these using a 
combination of RNA-seq analysis using GSEA software and in vitro as well as in 
vivo validations of the pathways. Our transcriptome analysis exemplifies the use 
of GSEA analysis in generating a hypothesis to guide bench-side experiments 
and uncover the fundamental mechanism underlying a biological phenomenon. 
 
Project 2: T-cell secreted IFNγ in regulating social behavior  
Recent seminal work demonstrated that adaptive immunity (primarily T-cell and 
its secreted molecules) is essential for proper brain functions such as cognition 
 125 
 
and learning (Derecki et al., 2010, Brynskikh et al., 2008, Kipnis et al., 2004). T-
cell dysfunction or overall immune deficiency is associated with several 
neurological and psychiatric disorders that present with social withdrawal 
(Ashwood et al., 2011, Gupta et al., 1998). Social behavior is crucial for the 
survival of an organism, and for higher-order species, mental-health (Filiano et 
al., 2016, Kennedy and Adolphs, 2012). Our preliminary results showed that mice 
lacking the adaptive immunity (SCID mice) have social behavior deficits. 
Specifically, meningeal T cells support social behavior as their partial depletion 
results in social deficiency observed in SCID mice. Though meningeal T cells are 
located in proximity to the brain parenchyma, they do not enter into the brain 
tissue under physiological conditions. Thus, we hypothesized that meningeal T 
cells support social behavior through its secreted molecules-such as cytokines.  
To identify which T-cell secreted cytokines/mediated-pathways are 
involved in regulating social behavior, we used a systems approach and 
performed meta-analysis of available transcriptomes representing various T-cell 
pathways and brain responses (Figure V-1). We downloaded and used most of 
the gene expression datasets from GEO and we implemented the GSEA as our 
main tool to integrate available transcriptomes. Specifically, transcriptomes of 
mice and rats brain cortices exposed to various stimuli were downloaded and 
analyzed (Figure V-1a). Brain responses transcriptional signatures were 
generated from the downloaded transcriptomes by retrieving genes upregulated 
at least twofold by average function following a brain stimuli. Similarly, T-cell 
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responses transcriptomes and signatures were downloaded and generated 
(Figure V-1b). Subsequently, we used GSEA to identify T-cell-mediated 
transcriptional signatures (IFN-γ, IL-4/IL-13, IL17, IL-10, TGF-β) in brain cortex 
transcriptomes of mice and rats exposed to different stimuli (social aggregation, 
sleep deprivation, stress, psychostimulants, antipsychotics and antidepressants) 
(Figure V-1c). To further validate the connectivity between any T-cell-mediated 
pathways and brain responses, we also performed GSEA using brain cortex 
transcriptional signatures and immune response transcriptomes (Figure V-1c). 
The connectivity between a T-cell-mediated pathway and a brain response was 
determined by the statistical significance of the GSEA output. Specifically, the 
following criteria were used to determine a pairwise connection: NES≥1.5 and a 
P<0.05. We then plotted all the connections between T-cell-mediated pathways 
and brain responses using circos plots, whose layout allows for exploring and 
uncovering novel interactions (Figure V-1d). We found that transcriptomes from 
cortices of rats exposed to social aggregation (group housing condition) were 
exclusively enriched in IFN-γ-mediated transcriptional signatures. This led us to 
hypothesize that T-cell secreted IFN-γ supports social behavior. We validated 
this hypothesis through behavioral assays using Ifng-/- mice. Greater details on 
the mechanism of how meningeal T-cell secreted IFN-γ alter neural circuit and 
control social behavior are provided in (Filiano et al. 2016).  
The reason we used the GSEA method in this context is two-fold:            
1) to integrate and group available transcriptomes by shared pathways; 2) to 
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uncover any interactions between T-cell-mediated pathways and brain 
responses. Implementing GSEA as a means to integrate available 
transcriptomes represents a novel approach of meta-analysis.  
IFN-γ is thought to be an important cytokine secreted by immune cells 
mediated anti-pathogen response. We recently showed that T-cell secreted IFN-γ 
can have a profound role in maintaining proper social behavior in mice. Since 
social behavior is crucial for the survival of a species, and increased social 
behavior increased the likelihood of spreading pathogens, we hypothesized that 
there was a co-evolutionary pressure that as sociability increases, anti-pathogen 
response also increases; IFN-γ pathway may have increased this co-evolution 
(Filiano et al., 2016). To test this hypothesis, we turned to the GEO database and 
searched for available brain transcriptomes in various organisms that were 
shown or indicated to represent distinctive social behavior. We identified brain 
transcriptomes of group-housing versus single-housing rats, domesticated versus 
wild-strain zebrafish and low versus high aggressive drosophila strains. In 
addition to the publicly available transcriptomes, we also conducted our own 
RNA-seq experiments on group-housing versus single-housing mice. We first 
used the GSEA to assess whether these brain transcriptomes exposed to various 
social stimuli were enriched in IFN-γ transcriptional signatures; it turned out that 
both transcriptomes of socially experienced rats and mice (acute group housing) 
were enriched in IFN-γ response signatures. Similarly, the transcriptome of a 
domesticated zebrafish strain, which demonstrated higher social interaction 
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(Barba-Escobedo and Gould, 2012), exhibited enrichment for an IFN-γ 
transcriptional signature derived from (López-Muñoz et al. 2009). Though 
drosophila lack T cells or IFN-γ, they contain JAK-STAT pathway which is 
canonically downstream of IFN-γ receptor signaling in higher species. We found 
that transcriptome of low-aggressive drosophila strains, which is a physiological 
correlate with socially experienced flies (Wang et al., 2008), was highly enriched 
with an anti-pathogen JAK/STAT-dependent transcriptional signature derived 
from GSE54833 and GSE2828. In conclusion, GSEA results demonstrated that 
IFN-γ transcriptional signatures are over-represented in social behavior-
associated brain transcriptomes ranging from insects to mammals, suggesting 
that the IFN-γ-mediated pro-social behavior effect is evolutionarily conserved.   
 To reaffirm that social aggregation upregulates IFN-γ responsive gene 
signatures, we examined the promoter regions of the highly upregulated ‘social’ 
genes in the aforementioned social-behavior-associated transcriptomes of mice, 
rats, zebrafish, and drosophila. Given our GSEA results, we hypothesized that 
these highly-regulated ‘social’ transcripts are controlled by the transcriptional 
factor STAT1, which is downstream of IFN-γ receptor signaling controlling IFN-γ 
target genes.  Specifically, top ranking ‘social’ genes were identified by selecting 
the leading-edge genes contributing to the enrichment of IFN-γ pathways and 
their differential expressions in social behavior-associated mice, rat, zebrafish 
and drosophila. Next, we extracted the promoter sequences (~200bp) of the 
‘social’ genes using UCSC Genome Browser (https://genome.ucsc.edu/). Using a 
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de novo motif discovery tool (MEME), we generated the over-represented 
transcriptional factor binding site (TFBS) motifs in the input promoter sequences. 
Subsequently, a motif comparison tool, namely Tomtom, was used to compare 
the top de novo generated motifs to a motif database (JASPER) containing TFBS 
motifs in vivo and in silico. A statistical significance (p-value) is calculated by the 
motif similarity analysis tool (Tomtom) by comparing the de novo motif to a 
known TFBS sequence. We found that the promoter regions of the ‘social’ 
transcripts in mice, rat, zebrafish and drosophila were enriched in STAT1 TFBS 
motifs, indicating that the social behavior upregulated genes were bona fide IFN-
γ targets. Taken together, we have shown that social aggregation/enrichment 
can upregulate an IFN-γ or anti-pathogen immune program even in the absence 
of an infection. This is in line with our hypothesis that IFN-γ pathway can mediate 
the co-evolution of the dynamic interaction between social behavior and anti-
pathogen response.   
 In conclusion, we have presented a novel GSEA-driven approach of meta-
analysis to integrate large numbers of transcriptomes. Using this approach, we 
showed that T-cell secreted IFN-γ is important in maintaining proper social 
behavior, and this dynamic interaction between the immune and nervous 
systems is evolutionarily conserved.  
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Project 3: Microglia phenotype switching in neurodegenerative diseases 
Microglia are the brain resident immune cells and play a pivotal role in 
maintaining brain homeostasis (Butovsky et al., 2014, Matcovitch-Natan et al., 
2016). They are constantly surveying the environment and react to homeostasis-
perturbing elements by initiating an inflammatory response (Wake et al. 2013). 
Previous studies revealed a unique molecular and functional transcriptional 
signature of microglia under homeostasis in the healthy brain (Butovsky et al. 
2013; Gautier et al. 2012; Hickman et al. 2013). The homeostatic microglia 
transcriptional signature is controlled by TGFβ signaling. It is well known that 
microglia are sensitive to the microenvironment stimuli and change phenotypes 
(i.e. transcriptional signature) during the course of CNS diseases (Chiu et al., 
2013, Holtman et al., 2015, Keren-Shaul et al., 2017, Kreutzberg, 1996, Orre et 
al., 2014, Perry and Holmes, 2014, Wang et al., 2015). Microglia lose 
homeostatic transcriptional signature and adopt an inflammatory phenotype in 
CNS diseases (Orre et al., 2014). Recent studies taking advantages of 
sequencing technologies have revealed a common-disease-associated microglia 
signature in neurodegenerative diseases (Chiu et al., 2013, Hickman et al., 2013, 
Holtman et al., 2015, Keren-Shaul et al., 2017, Orre et al., 2014). However, there 
were discrepancies in the common disease-associated microglia signatures, as 
each study was focused on a different disease model. Whether different 
microglia signatures in neurodegenerative diseases share a common 
transcriptional signature, and what is the underlying mechanism governing such 
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changes in transcription still remains unknown. To address these two questions, 
we followed an approach similar to the one established in Project 2 above. In 
particular, we used GSEA to perform a meta-analysis of microglia transcriptomes 
in different neurodegenerative diseases. Microglia transcriptomes from the 
following neurological disease were downloaded from GEO and re-analyzed: 
mouse models of neuropathic pain (GSE60670), chronic pain (GSE71133), Rett 
syndrome (Mecp2-/-) (GSE66211), lipid disorder (Mfp2-/-) (GSE66420), ALS 
(SOD1) (GSE433660), Alzheimer’s disease (5x FAD) (GSE65067), brain 
irradiation (GSE55968), and aging (GSE62420). Subsequently, microglia 
transcriptional signatures were generated by retrieving genes upregulated at 
least 1.5-fold by average function with a p value less than 0.01 (Student’s t-test) 
in disease conditions. The GSEA algorithm was applied to assess the overlap of 
microglia transcriptional signatures in various diseases. Our preliminary data 
using NanoString analysis suggest that phagocytic microglia shared similar 
transcriptional signature with microglia signatures in neurodegenerative 
diseases. To further validate our preliminary data, we conducted an RNA-seq 
experiment on phagocytic microglia and used GSEA to access phagocytic 
microglia signature enrichment in available microglia transcriptome of various 
neurodegenerative diseases. A Nom-P value less than 0.001 was used to 
determine pairwise transcriptome connectivity. We used circos plots to present 
our meta-analysis results and found that microglia transcriptomes in mouse 
models of aging, MFP2-/-, Alzheimer’s disease and brain irradiation shared a 
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common transcriptional signature. Of note, the common disease-associated 
microglia signature showed statistical significant overlap with a transcriptional 
signature of phagocytic microglia.  Taken together, these data suggest that 
microglia share a common transcriptional signature in neurodegenerative 
diseases which is induced by microglia phagocytosis.  
 Our NanoString analysis in three disease models (SOD1, EAE, APP-PS1) 
suggest that APOE pathway is significantly induced in microglia signatures in 
diseases. To explore the APOE signaling regulating microglia phenotype 
switching in neurodegenerative diseases, we performed RNA-seq on WT versus 
Apoe-/- microglia under both phagocytic and non-phagocytic conditions. We 
analyzed 1) APOE induced targets by selecting genes that were induced in 
phagocytic microglia but repressed in Apoe-/- phagocytic microglia, and 2) APOE 
repressed targets by selecting genes that were suppressed in phagocytic 
microglia but were restored in Apoe-/- phagocytic microglia. We then analyzed the 
promoter regions (~250bp upstream of transcriptional start site) of selected 
APOE induced- and repressed genes using a TFBS over-representation analysis 
tool oPOSSUM (Ho Sui et al., 2007). We found that APOE signaling represses 
homeostatic microglia signatures by suppressing transcriptional factor including 
Mef2a and Mafb; APOE signaling induces microglia signature in diseases by 
inducing transcriptional factors involving Bhlhe40 and Tfec.   
 Recent findings suggest that TREM2-pathway is activated in apoptotic 
neurons (Wang et al., 2015) that can induce microglia phagocytosis. As APOE 
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signaling activation is a hallmark of phagocytic/neurodegenerative microglia, we 
hypothesized that activation of APOE signaling in disease-associated microglia is 
TREM2-pathway dependent. To test this hypothesis, we derived Trem2-mediated 
transcriptional signature derived from GSE65067 (5XFAD/Trem2-/-), and used 
GSEA to determine the enrichment of Trem2-mediated transcriptional signature 
in microglia transcriptomes of various neurodegenerative models. We found that 
Trem2 pathway is enriched in microglia transcriptomes of aging, ALS, 
Alzheimer’s disease and lipid disorder (Mfp2-/-). In combination with APOE 
signaling activation in phagocytic microglia, our results suggest that microglia 
phenotype switching in neurodegenerative diseases is dependent on the 
TREM2-APOE pathway.  
 In summary, we used the GSEA method to perform meta-analysis of 
microglia transcriptomes and identified a unique microglia molecular signature 
that is common to several neurodegenerative models. A combination of pathway 
analysis and promoter sequence analysis revealed that the APOE-mediated 
gene regulatory networks regulate microglia phenotype switching in 
neurodegenerative diseases.   
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Figure V-1.Steps undertaken to perform the meta-analysis of T-cell mediated pathways in 
regulating brain responses. 
a. Rats and mice cortices transcriptomes were downloaded from GEO. b. Transcriptomes of T-
cell responses were downloaded from GEO and T-cell mediated pathway signatures were 
generated by retrieving genes upregulated at least twofold by average function following a 
cytokine stimulus. c. GSEA was implemented to integrate transcriptomes and determine the 
enrichment of T-cell response signatures in brain responses transcriptomes and vice versa. The 
connectivity between a T-cell pathway and a brain response is determined by NES ≥ 1.5 and 
Nom-P < 0.05. d. Circos plots were used to present the results of the meta-analysis of 
transcriptomes.  
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CHAPTER VI DISCUSSION 
Dysfunctional microglia and macrophages in MeCP2-null mice  
Increasing evidence has been demonstrating that non-neuron cells, such as 
brain resident microglia (Cronk et al., 2015, Derecki et al., 2012), astrocytes 
(Ballas et al., 2009), and oligodendrocytes (Nguyen et al., 2013), contribute 
significantly to the pathologies of Rett Syndrome. In Chapter II, we demonstrated 
that MeCP2 is broadly expressed in various peripheral macrophages 
populations, and its global loss leads to transcription impairment and reduced 
number of specific macrophage populations: microglia, perivascular meningeal 
macrophages, and intestinal macrophages. Re-expression of MeCP2 in 
Cx3CR1-expressing macrophages when administering tamoxifen in 
Cx3cr1creER/+MeCP2lox-stop/y mice resulted in attenuation of weight loss and 
increased lifespan. This result corroborates with earlier findings that MeCP2-
deficient myeloid-derived cells, including macrophages and microglia, are 
dysfunctional, and introduction of wild-type macrophages and microglia in 
otherwise null background can arrest pathologies in Rett Syndrome (Derecki et 
al., 2012). We have further provided the underlying mechanism of MeCP2-
deficient macrophage phenotypes through RNA-seq analysis of whole-brain 
microglia and peritoneal macrophages isolated from wild type and MeCP2-null 
mice, and in vitro and in vivo validations of pathways identified through RNA-seq. 
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We found that both microglia and peritoneal macrophages displayed 
impairment to three stimuli: glucocorticoid signaling, hypoxia response, and 
inflammatory response. These data implicate macrophage as a novel player in 
Rett Syndrome pathology. Our data also emphasize that, in addition to canonical 
nervous system cell types, MeCP2 expression is specific and important for the 
function of macrophage populations.  
 Our findings suggest both malfunction and loss of macrophages likely to 
be important contributors to somatic impairments in Rett Syndrome across 
multiple organ systems. However, the contribution to the neurological deficits is 
unclear, as MeCP2 itself plays a critical role in nervous systems function and 
global loss of MeCP2 results in serious general organ impairment. Therefore, 
dysfunctional neurons might increase the cellular stress and further activate 
MeCP2-deficient microglia and macrophages, aggravating their loss and 
maladaptive responses to the aforementioned stimuli. Such a positive feedback 
loop involving multiple cells types might explain the progressive worsening of 
systemic symptoms. These results are in line with a recent report that specific 
deletion of MeCP2 in Cx3cr1-expressing cells did not yield significant symptoms 
of Rett Syndrome (Schafer et al., 2016). We propose a model that neurons 
initiate and drive pathology, MeCP2-deficient microglia and macrophages further 
amplify neuronal-driven phenotypes, forming a positive feedback loop which 
progressively leads to death. Therefore, introduction of wild-type non-neuronal 
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cells could stop the vicious cycle and therefore arrest or blunt the progressive 
phenotype. 
 We have demonstrated that subsets of macrophage populations are 
particular venerable to MeCP2 deficiency, one of which are intestinal resident 
macrophages. It is well known that Rett patients also suffer from gastrointestinal 
abnormalities such as distension and constipation dysfunction (Chahrour and 
Zoghbi, 2007, Dunn, 2001). It is possible that the intestinal macrophages, which 
make up a significant proportion of the intestinal immune cells, could contribute 
to the gastrointestinal pathology due to either loss of favorable resident 
macrophages and/or dysfunction of macrophages in the absence of MeCP2.  Our 
results on functional defects and loss of tissue-resident macrophages connect 
with previous findings on insulin-like growth factor (IGF-1) in increasing the 
lifespan of MeCP2-null mice (Tropea et al., 2009) as macrophages have been 
indicated as one of the two largest sources of IGF-1 (Gow et al., 2010). 
Importantly, recombinant human IGF-1 has shown promising results in clinical 
trials (Khwaja et al., 2014). Therefore, it is conceivable that MeCP2-deficient 
macrophage contribute to overall pathology via loss of critical growth factor IGF1.  
  We found dysregulation of multiple gene expression programs being 
common in both microglia and a peripheral macrophage population-peritoneal 
macrophage. Given that macrophages throughout the body are very diverse 
given variation in location, context, and functions, this result suggests a more 
global role for MeCP2 in macrophage transcription regulation. These gene 
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expression programs might act alone or in concert depending on the exact stimuli 
present to the macrophage. For example, we found that many glucocorticoid-
induced transcripts were also hypoxia targets. Such transcripts might represent 
independent stimulus or synergic combination of both stimuli, which leads to 
complex transcriptional dysregulation.  
 Our validation studies confirmed a macrophage-intrinsic role for MeCP2 in 
the transcription regulation of inflammatory-, hypoxia- and glucocorticoid 
signaling pathways. We validated the role of MeCP2 on restraining glucocorticoid 
response in vitro using MeCP2-deficient BMDMs. MeCP2-deficient macrophages 
produced excessive responses when stimulated with low-dose of glucocorticoid, 
which have been previously shown to contribute to pathology in MeCP2-null mice 
(Braun et al., 2012). Furthermore, we showed that MeCP2 controls glucocorticoid 
target, Fkbp5, via binding directly to macrophage genome, supporting a direct 
role for MeCP2 in epigenetic regulation of macrophage response.  
 It is worth mentioning that MeCP2-null mice developed an activation of 
inflammatory program as disease progressed. This is exhibited by increased 
level of serum GCSF, which subsequently leads to severe neutrophilia. In 
addition, peritoneal macrophages and BMDM stimulated with TNF in vivo and in 
vitro, respectively, demonstrated dysregulated transcriptional response. These 
results implicated MeCP2 as a master regulator of TNF-mediated inflammatory 
responses in macrophages. Interestingly, TNF has been implicated as a non-
inflammatory cytokine and play an important role in development, homeostasis in 
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both CNS and outside CNS (Stellwagen and Malenka, 2006, Wheeler et al., 
2014).  Maladaptive response to TNF in neurons or other brain cells types might 
lead to defective brain development in the absence of MeCP2.  
 In summary, we have provided evidence that MeCP2 is a master 
epigenetic regulator in macrophages responses. Our study augments our 
understanding of the broad range of effects of MeCP2 on non-neuronal cell 
types, especially outside the CNS, a largely unexplored aspect in the studies of 
Rett Syndrome. We concluded that macrophages response in three signaling 
pathways were defective in the absence of MeCP2: glucocorticoid, hypoxia and 
inflammation via RNA-Seq studies. Our transcriptome analysis was an exemplar 
of using ‘omics’ data to generate effective and verifiable hypotheses and to guide 
bench-side experiments for studying the mechanisms underlying presenting 
biological phenomena. Given the diversity of macrophages populations 
throughout the body, we cannot predict the exact function in specific macrophage 
population. Future work on examining transcription regulation of unique 
macrophage populations’ response should consider the role of MeCP2 in 
macrophage activation. Provided the above, we implicate macrophages as a 
potentially therapeutic target for future Rett Syndrome therapies.  
 
 ‘Arms race’ between host and pathogens 
Despite being ‘immune privileged’, the CNS uses the help from the immune 
system under homeostasis and in diseases. The immune system, particularly 
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through T-cell and its secreted molecules, controls CNS development and 
function. In Chapter III, we demonstrated a novel role of cytokine IFN-γ in 
maintaining normal social behavior via meta-analysis of publicly available 
transcriptomes. Furthermore, we demonstrated that CNS neurons directly 
respond to IFN-γ derived from meningeal T cells to maintain an IFN-γ induced 
tonic inhibition. Lack of IFN-γ can lead to disinhibition of the PFC neurons and 
subsequently cause social deficits in mice. These data suggest IFN-γ acts as a 
rheostat to keep in check the baseline activation of neural circuits in supporting 
proper social behavior.  
 Earlier work on examining T-cell influences in the healthy brain has 
uncovered a vital role of a unique population, meningeal T cells, with respect to 
different effects on circuits and behaviors. However, how meningeal T cells 
influence brain behavior remains unknown as, though located in proximity of the 
brain tissue, they do not enter the brain parenchyma under non-pathological 
conditions. One of the hypotheses is that meningeal T cells affect brain behavior 
through one of their secreted molecules, such as cytokines. Identifying which 
cytokine affects which behavior is a challenging task, as meningeal T cells 
produce a myriad of cytokines having coinciding and/or synergic responses, 
although each can have a distinctive function. To identify specific cytokines effect 
on most brain behaviors, we carried out a meta-analysis of immune cell (and 
fibroblast) transcriptomes stimulated with different cytokines or a combination of 
cytokines, as well as rodent brain transcriptome exposed to different stimuli and 
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conditions. Using GSEA analysis and circus plot layout, we grouped 
transcriptomes into clusters based on experiments settings and transcriptome 
connectivity. Our analysis demonstrated that rodents which experience social 
environment induced transcriptional changes similar to those triggered by IFN-γ 
stimulation. We validated this result with mice lacking T cells or IFN-γ using 
three-chamber sociability assay. This result indicated a link between T-cell 
secreted cytokine IFN-γ  and social behavior.  
 A number of studies have reported altered IFN-γ levels in individuals with 
neurological disorders that present with social withdraw, such as depression and 
Autism Spectrum Disorders (ASD) (Dahl et al., 2014, Gupta et al., 1998). In the 
collected studies of depression, one study reported reduced IFN-γ levels in the 
post-mortem ventrolateral PFC region of people diagnosed with depression 
(Clark et al., 2016), while another study described contrasting results that the 
circulating IFN-γ levels were increased in individuals suffer from depression (Dahl 
et al., 2014). It is possible that these conflicting results are due to differential 
expression of IFN-γ in the blood versus in the CNS. Similarly, variations 
regarding immune dysfunction and reported IFN-γ levels can also be seen in 
ASD studies. Reduced number of terminally differentiated T cells was reported in 
autistic children (Saresella et al., 2009) . These T cells produced lower amounts 
of IFN-γ when isolated and stimulated in vitro with phorbol myristate acetate and 
ionomycin (Gupta et al., 1998). In contrast, other studies reported increased 
levels of IFN-γ detected both in the brain (Li et al., 2009) and blood (Masi et al., 
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2015). Collectively, these results indicate ASD as a heterogeneous disorder, with 
both too much and too little IFN-γ or immune disruption in any direction could 
lead to disease.  
 Social behavior is crucial not only for survival and reproduction of a 
species (host) but also for the transmission and evolution of pathogens. Our 
transcriptome analysis using public data source demonstrated that the brain 
transcriptome of rat, mice, zebrafish and flies exhibited enrichments of IFN-γ-
induced transcriptional signatures even in the absence of any infection. Of 
particular note, brain transcriptome of flies demonstrated increased expression of 
primordial Janus kinase (JAK)-STAT-induced transcripts, though flies lack IFN-γ 
itself and adaptive immunity. These results implied a conceivable theory: IFN-γ 
drives pro-social genes to increase social interactions of the host and its 
conspecifics, which also benefits the pathogen to spread. Higher species may 
have evolved IFN-γ to combat pathogen more efficiently as sociability increases. 
Furthermore, in combination with the well-studied sickness behavior, one of 
which is pathogen-induced social withdraw, we proposed a plausible hypothesis 
that the complex social behavior (pathogen-induced pro-social versus host-
induced social withdraw) may have evolved as a result of an “arm race’ between 
pathogens and hosts (Filiano et al., 2017, Filiano et al., 2016, Kipnis, 2016). Our 
discovery on the novel role of IFN-γ in promoting social behavior fits this dynamic 
interaction between the pathogens and hosts.  
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 Taken together, our results indicate that impaired immunity may cause 
numerous neurological and psychiatric disorders present with social behavior 
deficits. We provided a detailed mechanism on how immune cell-derived 
molecules can alter neural circuit and affect brain behavior. Given the vast 
number of cytokines or cytokine-like molecules secreted by the immune system, 
and the growing appreciation that the immune and nervous system interact 
closely, these immune agents constitute a promising target reservoir for the 
therapeutical intervention of neurological disorders.  
 
Disease-associated microglia 
It is known that microglia adopt a different phenotype in CNS diseases.  In 
Chapter IV, we identified a unique population of disease-associated microglia 
(MGnD) that is commonly found in several neurodegenerative conditions in 
mouse models. Pathway analysis of these transcriptome revealed that MGnD 
phenotype was induced by activation of the TREM2-APOE pathway. Our studies 
showed that phagocytic microglia following injecting apoptotic neurons and 
neuronal filaments also induced MGnD by suppressing TGFβ-mediated 
homeostatic signature. Our results suggest a novel role of APOE in the 
regulation of newly identified microglia population (MGnD) and implicate the 
APOE-TREM2 pathway as a potential therapeutic target to restore homeostatic 
microglia function in Alzheimer and related diseases.  
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 We have demonstrated that APOE-dependent MGnD are located in close 
proximity to amyloid plaques in a mouse model and patients’ brain of Alzheimer’s 
disease. Moreover, APOE-mediated MGnD and dystrophic neuritis form a 
complex around amyloid plaques, forming a unique microenvironment. Our 
results are in line with literature reports on the positive role of APOE in promoting 
amyloid plaques formation in Alzheimer’s disease (Huang et al., 2017, Kim et al., 
2012, Liao et al., 2014a). Moreover, we showed that the APOE-suppressed 
homeostatic microglia signature is inversely correlated with AD pathology in 
human. Therefore, it is conceivable that APOE-mediated MGnD may contribute 
to AD pathology via promoting amyloid plaque formation.  
 Our promoter analysis of APOE targets revealed that APOE induces 
MGnD signature via Bhlhe40, and suppresses homeostatic signature via PU.1 
and Mef2a. Therefore, it forms bifurcate gene regulatory networks to induce 
MGnD and suppresses homeostatic signature. Promoter analysis using 
oPOSSUM demonstrated that upstream promoter regions of APOE-repressed 
genes were enriched with PU.1 and MEF2 transcription factor binding sites, and 
our in-house motif analysis using TRANSFAC database also confirmed that (data 
not shown). Interestingly, previous studies found that PU.1 binding sites are 
enriched in the enhancer regions of microglia; PU.1 can cooperate with Mef2a 
family to drive gene expressions specific in microglia. These results suggest that 
APOE signaling may suppress homeostatic signature by inhibiting Mef2a binding 
to the promoters and/or enhancers of microglia genes.  Of note, we also 
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observed that transcription factor smad3 is repressed by APOE. Given that 
smad3 is primarily induced by TGFb signaling pathway, it is likely that APOE 
represses TGFb-mediated homeostatic signature via smad3. Our promoter 
analysis also proposed a novel transcriptional factor Bhlhe40 in mediating APOE-
induced MGnD transcriptional signature. This result will be validated in future 
studies. 
 The role of TREM2 protein, one of the major risk factors for AD, has been 
hotly debated in the context of neurodegenerative diseases. Our pathway 
analysis of microglia transcriptomes under several diseased conditions, including 
Alzheimer’s disease (5xFAD), ALS (SOD1 model), cerebellar degeneration 
(MFP2 deficiency) and aged mice, showed that neurodegenerative conditions 
induced changes in gene expression that are similar to those triggered by 
activation of TREM2 pathway. We have further provided experimental validation 
through genetically deleting Trem2 in both APP-PS1 and SOD1 mice. We found 
that deletion of Trem2 in these mice restored homeostatic microglia signature via 
suppressing APOE pathway.  
 All in all, these results provided evidence that the APOE-TREM2 pathway 
plays an important role in microglia phenotype switch in diseases, and implicate 
microglia as therapeutic targets in AD and related conditions. Importantly, we 
identified a unique population of microglia subset (MGnD) that is common to 
neurodegenerative diseases like AD and ALS and present in aged brains. The 
mechanism for such microglia phenotype switch is possibly attributed to neuronal 
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apoptosis and activation of APOE-TREM2 pathway. Restoration of microglia 
homeostatic function by targeting APOE-TREM2 may be beneficial in AD and 
other neurodegenerative conditions. However, this possibility should be 
approached with caution as it will be important to take into consideration the 
different APOE genotypes and TREM2 polymorphism in AD patients.   
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